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ABSTRACT 
ROLE OF EPS15 HOMOLOGY DOMAIN-CONTAINING PROTEIN 4 (EHD4) IN THE 
KIDNEY 
Shamma S. Rahman, Ph.D. 
University of Nebraska Medical Center, 2018 
Supervisor: Erika I. Boesen, Ph.D. 
In the kidney, endocytic recycling regulates the abundance of channels and transporters 
in the membrane of the tubular epithelium, and thereby controls the kidney’s ability to 
regulate water homeostasis. In recent years, a family of proteins called Eps15 homology 
domain-containing (EHD) proteins has emerged as important regulators of the endocytic 
recycling pathway. Mammals express four paralogs of EHD proteins, EHD1-4, that are 
expressed in different tissues. Although EHD4 is expressed in the kidney, the specific 
physiological role of EHD4 in the kidney remains unknown. Therefore, this dissertation 
was focused to elucidate the physiological role of EHD4 in the kidney. In the mouse kidney, 
EHD4 was found to be expressed most abundantly in the inner medullary collecting duct 
(IMCD), a site for fine-tuning final urine concentration. Studying the renal parameters of 
Ehd4-/- (EHD4-KO) mice showed that EHD4-KO mice had a higher urine flow and lower 
urine osmolality than wild-type (WT) mice. EHD4 was found to be expressed in the 
hypothalamus, but its deletion did not affect the plasma osmolality or arginine vasopressin 
(AVP) excretion. EHD4-KO mice were able to exhibit anti-diuretic responses to 24-h water 
restriction similar to the WT mice, suggesting that the diuretic phenotype of EHD4-KO 
mice is due to defective renal water and solute handling. Formation of a concentrated 
urine requires the presence of the renal medullary osmotic gradient, partially contributed 
by renal urea handling, and fine-tuning of water reabsorption via aquaporin (AQP) 2 in the 
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IMCD. Given the abundant expression of EHD4 in the IMCD, it was hypothesized that 
EHD4 regulates AQP2 trafficking in the principal cells and renal urea handling. Both in 
vivo and in vitro analysis showed that in the absence of EHD4, the apical membrane 
abundance of AQP2 was significantly attenuated. EHD4 was also found to regulate 
basolateral membrane abundance of AQP4 in principal cells. Although EHD4 was found 
to co-localize with AQP2, immuno-complex containing AQP2 did not show the presence 
of EHD4, suggesting a lack of direct physical interaction between the two proteins. 
Additionally, EHD4-KO mice had higher urea excretion than WT mice, suggesting a 
dysfunctional urea handling in these mice. To delineate the exact role of EHD4 in renal 
urea handling, mice were subjected to a series of experiments involving intake of modified 
protein diets, which confirmed a role of EHD4 in the regulation of renal urea handling. 
Overall, this dissertation describes a novel role for EHD4 in the regulation of AQP2, AQP4, 
and renal urea handling in the kidney. 
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1 Parts of the material presented in this section was previously published in:  
1Rahman, S. S., and Boesen, E. I. Outside the mainstream: novel collecting duct proteins 
regulating water balance. Am. J. Physiol. Renal Physiol. 311: F1341-F1345 (2016) 
 
2Rahman, S.S., Moffitt, A. E. J., Trease, A., Foster, F. W., Storck, M., Band, H., Boesen, E. I. EHD4 
is a novel regulator of urinary water homeostasis. FASEB J. (2017) 
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Physiological functions of the kidney 
The kidney has three broad physiological functions: secretion of hormones, 
gluconeogenesis, and maintenance of extracellular homeostasis of pH and blood 
electrolytes. The functional unit of the kidney, called the nephron, consists of two parts: 
the glomerulus, which is involved in the ultrafiltration of the blood, and the tubule, which 
consists of specialized epithelial cells involved in the reabsorption and secretion process 
(65).  
The renal corpuscle consist of glomerular capillaries and the glomerular capsule 
known as Bowman’s capsule. Blood undergoes filtration as it passes through the renal 
corpuscles, wherein large cells and proteins are retained in the blood in the glomerular 
capillaries, and water and solutes freely pass into the Bowman’s space. The kidneys filter 
180 liters of blood each day in an average 70 kg human and the rate at which the kidney 
filters blood is called glomerular filtration rate (156). 
The filtrate entering the Bowman’s space then passes into the nephron tubules. 
The ultrafiltrate undergoes regulated stages of reabsorption, which involves removal of 
water and solute from the tubular fluid and transporting it back to the blood, and secretion, 
which involves releasing molecules into the tubular fluid from the epithelium as it passes 
down the nephron tubules. The first part of the nephron tubule is the proximal convoluted 
tubule. The apical (luminal) surface of the epithelial cells of the proximal tubules contains 
dense microvilli and the cytoplasm of these cells contains numerous mitochondria, 
allowing these cells to participate in the bulk reabsorption of water and solute. Next, the 
filtrate enters the loop of Henle, which consists of thin descending limb, thin ascending 
limb, and thick ascending limb. Next, the filtrate passes to the distal convoluted tubule, 
which is lined by small cuboidal epithelial cells. Finally the filtrate reaches the collecting 
duct, which consist of two major types of cells: intercalated cells, involved in acid-base 
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regulation, and the principal cells, involved in the fine-tuning of urine volume and 
composition. An adult human produces 1 to 2 liters of urine in average, which is regulated 
by factors like the hydration state, physical activity, environmental conditions, weight, and 
the health of the person (65, 156).   
Urine formation and composition 
Urine formation begins as soon as the ultrafiltrate enters the proximal tubules, 
where complete reabsorption of the essential molecules, such as glucose and amino 
acids, takes place. About 65-70% of filtered sodium is reabsorbed in the proximal tubule 
via the sodium-hydrogen exchanger (NHE) (115) and sodium-glucose cotransporter, lining 
the apical membrane of the proximal tubules. Sodium reabsorption in the proximal tubule 
is coupled to water reabsorption, wherein water enters and exits the epithelial cells via 
aquaporin (AQP) 1(140).  
The descending thin limb of the loop of Henle is highly permeable to water due to 
the presence of AQP1 (23, 153), but impermeable to sodium due to a lack of sodium 
channels and transporters in the membrane (95). On the other hand, the ascending limb 
of the loop of Henle is permeable to sodium due to the presence of sodium-potassium-
chloride cotransporter 2 (NKCC2) (62), as well as NHE, that allows reabsorption of 25% 
of filtered sodium. However, this section of the nephron is completely impermeable to 
water due to a lack of any aquaporin water channels (162). Such an arrangement, which 
is discussed in detail in the following section, allows the formation of concentrated urine. 
The distal convoluted tubules of the nephron contains the sodium-chloride cotransporter 
(NCC) (52), which participates in the reabsorption of 5% of filtered sodium. The collecting 
duct offers the final stages of regulation of the volume and composition of urine, and about 
5% of sodium reabsorption occurs via the epithelial sodium channel (ENaC) (54). Water 
reabsorption in the distal parts of the nephron is variable and this variability allows the 
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kidney to regulate the water excretion and reabsorption to maintain a constant water 
balance. A detailed role of the water channels of the collecting duct is discussed in the 
following section. 
Water balance 
Maintaining extracellular fluid osmolality is integral for survival. Imbalance in body 
water can have adverse effect on the cell size and function. The hypothalamus, 
neurohypophysis, and the kidney are involved in the regulation of water balance in the 
body (33).   
Clinical implications of water imbalance 
A failure to maintain water balance can result from different forms of urine-
concentrating defects. Diabetes insipidus is such a disorder where the patient produces 
large volumes of urine. Defects in the synthesis or secretion of arginine vasopressin (AVP) 
can result in central diabetes insipidus (2), whereas unresponsiveness of the kidney to 
AVP can cause nephrogenic diabetes insipidus (85, 111). Unmanaged polyuria, such as 
during diabetes insipidus, can cause the osmolality of the plasma to elevate and result in 
an often-fatal condition known as hypernatremia. Treatment options for these diseases 
are limited and a major limiting factor in designing better therapies for such conditions of 
water imbalance is the lack and gap in the knowledge of the detailed molecular and cellular 
pathways that regulate the hypothalamic-neurohypophyseal-renal axis. The physiological 
process of maintaining a net zero water balance is very tightly regulated at the cellular 
level. It is, therefore, essential to study these pathways to form a comprehensive 
knowledge of how the body regulates water balance. 
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Role of the collecting duct in fine-tuning water balance 
The ability of the kidney to produce a concentrated urine (i.e. reabsorbing more 
water) or dilute urine (i.e. excreting more water) depends on the state of water-
permeability of the nephron sections. The water-permeability of the nephron structures 
can be altered by acutely regulating the paracellular and transcellular water flow. The 
paracellular route is regulated by the tight junction proteins, which act as zippers to seal 
the intercellular spaces between adjacent epithelial cells (73). The tight junction proteins 
along the thick ascending limb and collecting duct are highly expressed, making these 
segments water-impermeable. However, the water-permeability of the collecting duct can 
be increased by AVP by increasing the transcellular route of water reabsorption via the 
regulation of the membrane trafficking of aquaporins (AQPs) of the IMCD.  
Aquaporins of the kidney 
Water homeostasis is a critical process involving the coordinated action of the 
hypothalamus, including the thirst mechanism and control of AVP release, and the 
kidneys, where water is either reabsorbed or excreted in the urine. Reabsorption of water 
from the tubular lumen into the interstitium occurs via specialized water channels called 
AQPs (96, 198). The kidney expresses different subtypes of AQPs in different segments 
of the nephron. AQP1 is constitutively expressed in the apical membrane of the epithelium 
of proximal tubules and thin descending limb of the loop of Henle (96). Although AQP1-
mediated water transport in these proximal sections of the kidney contribute to the bulk 
reabsorption of water, the collecting duct (CD) represents the key site for fine-tuning of 
water balance by the kidney. AQP2, the apical water channel of the principal cells of the 
CD, is the only AQP whose presence on the apical membrane of the principal cell is 
regulated by AVP, and as a result determines the water permeability of the CD (198). 
Humans harboring mutation in the AQP2 gene develop nephrogenic diabetes insipidus 
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(34). The principal cells of the CD constitutively expresses AQP3 and AQP4 on the 
basolateral membrane (140).  
General structure and expression profile of AQP2 
AQP2 is the water channel found in the apical plasma membrane of principal cells 
of the collecting ducts of the kidney. Cloning and expression analysis of AQP2 was first 
performed in 1993 (51) and since then the regulatory mechanisms of AQP2 has been 
extensively studied. AQP2 is composed of 6 transmembrane α-helices, with both the 
amino and carboxyl ends facing the inside of the cell (59). The expression and trafficking 
of AQP2 in the principal cells is regulated by AVP and is required for the water permeability 
of the collecting duct of the kidney. A large number of different mutations of AQP2 gene 
have been found and a defect in its trafficking causes nephrogenic diabetes insipidus, 
where the kidney is unable to reabsorb water and concentrate urine (128). However, most 
of the time, nephrogenic diabetes insipidus occurs due to a mutation of the vasopressin 
V2 receptor (129). 
AVP-dependent regulation of AQP2 
AVP is a major regulator of renal water reabsorption and exerts its effects on the 
kidney through its G-protein coupled receptor. The collecting duct expresses V2 receptor, 
a Gs-coupled receptor, on the basolateral membrane of the principal cells. Similar to other 
Gs-coupled receptors, activation of V2 receptor increases the level of cyclic-AMP (cAMP) 
and activates protein kinase A (PKA) in the principal cells. Extensive studies on rodents 
have been performed to understand the effect of AVP on the regulation of AQP2 in 
principal cells. AVP-mediated regulation of AQP2 can be classified as being short-term, 
which occurs within minutes, and as long-term, which can take place over several hours 
to days (75, 140).  
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The short-term regulation of AQP2 by AVP involves the changes in the cellular 
localization of AQP2 (139). In the presence of AVP, localization of AQP2 is shifted from 
the cytoplasm to the apical plasma membrane, and is mediated by a combination of both 
an increased exocytosis and inhibition of endocytosis of AQP2-containing vesicles (18). 
AVP mediates the changes in the localization of AQP2 by changing the phosphorylation 
status of AQP2 that results in an increased forward trafficking of the channel and retention 
of AQP2 in the apical membrane (126). Exocytosis of AQP2 is dependent on the 
phosphorylation of the serine-256 residue (50), whereas the phosphorylation of serine-
269 strongly favors the retention of AQP2 in the apical plasma membrane and inhibits its 
endocytosis (124). AVP also reduces the phosphorylation on serine-261 residue (113), 
although the role of this phosphorylation site in the trafficking of AQP2 remains unknown. 
In addition to inducing changes in the phosphorylation status of AQP2, AVP also regulates 
the redistribution of AQP2 by modulating the cytoskeletal proteins such as actin (145). 
The long-term effect of AVP on AQP2 involves changes in the total abundance of 
the channel in principal cells (67), which is regulated in at least two ways. Firstly, AVP 
increases the half-life of AQP2 protein in principal cells, such as from 9 to 14 hours in 
cultured principal cells (169). Secondly, AVP increases the transcription of the AQP2 
gene, which ultimately increases the translation of AQP2 mRNA (120). The promoter 
region of AQP2 has binding sites for cAMP responsive element binding (CREB) protein, 
the binding of which increases the transcription of AQP2 (209).  
Much progress has been made into understanding the molecular mechanisms 
involved, especially as they relate to the classical AVP-AQP2 axis (18, 66, 75, 140). 
However, recent studies have implicated several novel proteins and local factors in the 
regulation of water balance, as discussed below, and these may or may not act by 
influencing the components of the classical linear AVP-AQP2 axis upstream of AQP2.  
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AVP-independent regulation of AQP2 
Several studies have called into question whether cAMP is necessary for apical 
trafficking of AQP2 downstream of activation of G protein-coupled receptors such as the 
V2-receptor. A recent study highlighted a disconnect between the time course of cAMP 
elevation in response to stimulation of these Gs coupled receptors and the apical 
membrane targeting of AQP2 (150). Treatment of cells with an adenylyl cyclase (AC) 
inhibitor did not prevent AQP2 membrane targeting (150), and AC6-null mice do not 
increase cAMP in response to AVP yet still are able to concentrate their urine in response 
to water restriction or d-deamino-arginine vasopressin (dDAVP), an analog of AVP 
administration (161). Accordingly, cAMP-independent signaling pathways for AQP2 apical 
trafficking in response to activation of these receptors await elucidation. 
Regulation of AQP2 by prostaglandin E2 (PGE2) 
One of the major local factors influencing the trafficking of AQP2 in principal cells 
is prostaglandin E2 (PGE2). PGE2 is a lipid mediator derived from the metabolism of 
arachidonic acid, which is converted to PGE2 by the sequential actions of 
cyclooxygenase-1 and -2 and PGE synthase enzymes. PGE2 exerts its influence via 4 
different types of G protein-coupled prostanoid receptors, namely EP1-4 (14). The CD 
expresses all 4 of these receptors. EP2 is only expressed in the cortical collecting ducts 
(84), whereas the other EPs are expressed all along the CD (6, 15, 16). EP2 and EP4 are 
coupled to Gs protein, whereas EP1 and EP3 are coupled mainly to Gi protein (14). This 
differential coupling pattern of EPs results in evoking opposite effects on AQP2 trafficking, 
and ultimately on urine-concentrating mechanisms. 
In rat IMCD, PGE2 and agonists of EP1 and EP3 have been shown to decrease 
the AVP-induced water permeability and AQP2 trafficking at a post-cAMP level (78, 132, 
191, 211). EP1 retards AQP2 trafficking by activating protein kinase C (PKC) that results 
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in an increase in the endocytosis of AQP2. In the CD, EP3 couples to Gi and inhibits the 
synthesis of cAMP, thereby inhibiting the exocytosis of AQP2. Another interesting way by 
which PGE2 could increase diuresis is by acting on the EP2 located in the papillary 
interstitial cells. EP2 is the only prostanoid receptor expressed in the papillary interstitial 
cells and binding of PGE2 to EP2 increases hyaluronan synthesis in these cells (165, 
213). Hyaluronan has a high capacity to bind water, and thereby alter the papillary matrix 
and inhibit water flow (166). Hence, PGE2 can reduce water permeability and increase 
diuresis within the IMCD through acting on EP1, EP2, and EP3. 
Transcriptional regulation of AQP2 gene transcription 
Transcriptional regulation represents an important means of long-term regulation 
of CD function. Unsurprisingly, deletion of a number of transcription factors results in renal 
developmental abnormalities, phenotypes of nephrogenic diabetes insipidus or urinary 
concentrating defects (109, 210, 214). However, several such transcription factors have 
additionally been shown to play a role in water handling independently of developmental 
effects. Using an inducible system, post-developmental deletion of GATA2 from the 
nephron induced polyuria and revealed an important role of GATA2 as a direct 
transactivator of AQP2, as well as regulating V2R and AQP3 mRNA levels, suggesting 
GATA2 promotes water conservation via multiple mechanisms (210). AVP-independent 
increases of AQP2 by the ligand-activated transcription factor Farnesoid X receptor was 
also recently shown to contribute to regulation of urine volume (214). Hyperosmotic stress 
increases the phosphorylation of TAZ (transcriptional coactivator with PDZ-binding motif, 
also known as Wwtr1), which is followed by increased physical interaction between TAZ 
and nuclear factor of activated T cells 5 (NFAT5), reducing NFAT5 activity (80). NFAT5 is 
an osmoregulatory transcription factor that upregulates the expression of AQP2 in 
response to calcium and osmotic stress (109), suggesting that TAZ may help to fine-tune 
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both NFAT5 and AQP2 expression under conditions of osmotic stress. Together, these 
recent developments show that there is far more to the transcriptional regulation of CD 
water handling proteins than the classical transcription factor CREB. 
Post-translational modifications of AQP2 in principal cells 
The role of phosphorylation of AQP2 has been extensively studied by several 
groups, and it can be readily appreciated from these numerous studies that 
phosphorylation of AQP2 is one of the most highly regulated post-translational 
modifications of the channel (125). As described above, AVP increases the forward 
trafficking of AQP2 to the apical plasma membrane by changing the phosphorylation 
status of the channel. Phosphorylation of serine-256 residue of AQP2 was the first to be 
identified (50), and studies over the last decade have identified other phospho-residues, 
namely serine-261, serine-264, and serine-269 (125). Although PKA is the most well-
defined kinase involved in the phosphorylation of AQP2, the channel has other putative 
sites for other kinases such as PKG, PKC, and casein kinase II (18). Each of the 
phosphoforms of AQP2 have an effect on the cellular localization of AQP2. 
Phosphorylation of serine-256 residue increases the exocytosis of AQP2 and is required 
for facilitating the phosphorylation of serine-264 and serine-269 (70). Phospho serine-269 
AQP2 has only been observed exclusively on the apical membrane, suggesting that the 
phosphorylation of this residue increases the retention of AQP2 in the apical membrane 
(124). Phospho serine-264 AQP2 resides in the compartments close to the plasma 
membrane and in early endocytic pathways (48), whereas phospho serine-261 AQP2 is 
localized in compartments different from the endoplasmic reticulum, Golgi, and lysosomes 
(71). Phosphorylation of AQP2, therefore, is a critical process in determining the cellular 
localization of the channel in the principal cells.  
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Ubiquitination is another form of post translational modification of AQP2 whereby 
the lysine-270 residue of AQP2 undergoes short-chain ubiquitination and mediates the 
endocytosis and degradation of AQP2 (82). In addition to ubiquitination, AQP2 also 
undergoes complex N-glycosylation (7, 68); however, the role of glycosylation of AQP2 is 
unclear. In oocytes, mutants of non-glycosylated and glycosylated AQP2 are retained in 
the endoplasmic reticulum due to failure to properly fold the protein (116). In another study 
it has been shown that glycosylation of AQP2 is necessary for the exit of the protein from 
Golgi and important for membrane trafficking (68). Together, these studies on the post-
translational modifications of AQP2 have shown that these processes are important for 
the cellular localization and function of AQP2, although the knowledge of these processes 
is far from complete. 
Membrane localization of AQP2 in principal cells 
The presence of aquaporins in the apical and basolateral membranes of select 
regions of the nephron is critical for water reabsorption from the tubular fluid. The cAMP-
dependent PKA-mediated phosphorylation of AQP2 downstream of vasopressin V2 
receptor activation by AVP has long been recognized to promote the forward trafficking of 
AQP2 into the apical membrane. The trafficking of AQP2 to the cell membrane from the 
intracellular vesicles involves passage of the channel through the Golgi apparatus and 
endosomal compartments. The insertion of AQP2 channel into the plasma membrane 
involves numerous fission and fusion steps that are regulated by various proteins such as 
the SNARE complex (18).  
As described above, the trafficking of AQP2 in principal cells is regulated by factors 
such as AVP and PGE2, but under non-stimulated conditions, AQP2 can undergo 
constitutive recycling (18). In LLC-PK1 cells, a porcine kidney cell line, inhibition of clathrin-
mediated endocytosis resulted in an increased accumulation of AQP2 in the plasma 
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membrane, which was independent of serine-256 phosphorylation (112). In another study, 
inhibition of AQP2 recycling in LLC-PK1 cells resulted in accumulation of the channel in 
the trans-Golgi (64), showing that recycling of AQP2 is critical for the membrane 
accumulation of the channel. Additionally, induction of actin depolymerization in cultured 
IMCD cells in the absence of any hormonal stimulation increased the accumulation of 
AQP2 in the plasma membrane (189), indicating the importance of the cytoskeleton in the 
trafficking of AQP2. All these observations show that a disruption of either the endocytosis 
or exocytosis of AQP2 can change the amount of AQP2 in the plasma membrane, implying 
that the constitutive recycling of AQP2 is a very dynamic process with endocytosis in 
equilibrium with exocytosis (167). Currently, there is a major gap in understanding this 
constitutive recycling of AQP2 because the molecular machinery for these processes is 
poorly characterized.  
Roles of AQP3 and AQP4 in the CD 
 The principal cells of the CD express AQP3 and AQP4 in the basolateral 
membrane, providing an exit pathway for the water that enters these cells through the 
AQP2 in the apical membrane. Mice lacking AQP3 develop severe polyuria (114). Albeit 
less well-studied than AQP2, differences in AQP3 expression or localization to the 
basolateral membrane can also affect water reabsorption across the CD. Similar to AQP2, 
AVP regulates AQP3 transcription (36); however, recent studies are showing AVP-
independent pathways can also regulate AQP3. Mice lacking acyl-CoA binding protein 
(ACBP), a protein involved in transporting acyl-CoA esters between different enzymes, 
were found to have slightly higher urine flow under basal conditions and a reduced ability 
to conserve water during water restriction, but no apparent difference in sodium or 
potassium handling (101). Expression and basolateral localization of AQP3 was reduced 
in the ACBP knockout mice, with no apparent changes in the expression and localization 
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of AQP1, 2 or 4 (101). Fatty acyl-CoAs can serve as allosteric regulators of cellular 
proteins such as ryanodine-sensitive Ca2+ release channels (40), which are in turn 
important regulators of AQP2 distribution in principal cells (24), however the mechanism(s) 
by which ACBP regulates AQP3 expression and localization is unknown.  
AQP4, along with AQP3, is expressed in the basolateral side of principal cells; 
however, unlike AQP2 or AQP3, its abundance is not regulated by AVP (140). Deletion of 
AQP4 in mice results in polyuria that is milder than that seen in AQP3-null mice (25). 
Unlike AQP2 and AQP3, the expression of AQP4 is unaffected by water restriction (192). 
Moreover, sorting of AQP3 and AQP4 to the basolateral membrane occurs separately in 
the Golgi (3), indicating that there are several non-overlapping cellular pathways 
regulating these aquaporins in the CD.   
Over the decades, studies on the AQPs of the CD have elegantly shown that the 
cellular apparatus involved in the regulation of these water channels is very complex, and 
far from being completely characterized. The presence of these water channels in their 
appropriate membrane is crucial in determining the water permeability of the CD, which in 
turn regulates the ability of the kidney to maintain water balance. While the AVP-mediated 
cellular trafficking of AQP2 has been somewhat well-characterized, the constitutive 
recycling of AQP2 and the other AQPs remain largely unexplored. It is, therefore, 
imperative to accurately identify and characterize proteins and molecular mechanisms that 
regulate the cellular localization of these water channels of the CD. Moreover, as the 
discussion on the role of the kidney and hypothalamus in the maintenance of water 
balance progresses in the upcoming sections, the importance of the cellular trafficking of 
other channels and transporters in the regulation of water balance can be appreciated.
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Role of the renal medullary interstitium in fine-tuning water balance 
The final steps in the maintenance of osmotic homeostasis occur in the kidney, 
and involves the production of a hypoosmotic or hyperosmotic urine depending on the 
hydration state of the individual. The osmolality of the renal medullary interstitium provides 
an osmotic driving force to allow water to exit the tubules, thereby allowing urine to be 
concentrated. The osmolality of the renal medulla can be increased significantly during 
states of dehydration to increase the amount of water that is reabsorbed, and thereby, 
allowing the formation of a hyperosmotic urine, whose osmolality is higher than that of the 
plasma (172, 174).  
The structural arrangement of the nephron is crucial in the generation of the 
osmotic gradient of the renal medullary interstitium. Three features of the nephron 
structure come into play to establish this gradient. First, the nephron forms a hairpin loop 
to allow water and solute exchange between the descending thin limb and the ascending 
thin limb (174). Second, the ascending thin limb is impermeable to water, but permeable 
to sodium due to the presence of NKCC2 that actively transports sodium from the tubular 
fluid into the interstitium, allowing the concentration of the interstitium to build up. Third, 
the concentration gradient of the interstitium allows reabsorption of water from the water-
permeable, but solute-impermeable, descending thin limb. This process, termed 
countercurrent multiplication, establishes the gradient and contributes to one half of the 
maximal medullary concentration, with the other half contributed by urea recycling (87). 
Urea is passively reabsorbed from IMCD via urea transporters of collecting duct and 
enters the interstitium. The reabsorbed urea then re-enters the thin loop of Henle back 
into the filtrate, passes the distal tubules and reaches the IMCD, from where it again 
undergoes passive reabsorption. This re-circulation of urea within renal medulla helps in 
building up the osmotic gradient (74, 206). 
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The preservation of the osmotic gradient of the renal medullary interstitium is 
achieved by a process called countercurrent exchange that involves the vasa recta. The 
special arrangement of the vasa recta prevents the escape of the solutes from the renal 
medulla and thereby stops the dissipation of the gradient (130). Two features of the vasa 
recta allows the preservation of the gradient. First, the blood flow to the renal medulla is 
very low. Although the kidney receives about 25% of the cardiac output, most of the renal 
blood flow is directed to the outer cortex and the renal medulla receives only less than 2 
to 5% (127) of this blood. Second, the arrangement of the two limbs of the vasa recta 
allows countercurrent exchange. In the descending limb of the vasa recta water diffuses 
out of the plasma and solutes from the renal interstitium enters the plasma, thereby making 
the plasma in this side hyperosmotic. In the ascending limb of the vasa recta, the water 
diffuses back into the blood and solutes diffuse back to the interstitium. In this way the 
washing out of the gradient is prevented and the gradient remains preserved. 
As described above, urea plays an important role in both the generation and 
preservation of the renal medullary gradient, the integrity of which is crucial in the 
maintenance of water balance. The following section discusses the various urea 
transporters of the kidney that are involved in the renal urea handling. 
General structure and expression profile of urea transporters 
Urea was first isolated from the urine by Hillaire-Marin Ronelle in 1773 and has 
been long recognized as an important biological molecule in the urine-concentrating 
mechanism (206). Being a water-soluble molecule, urea has low permeability through lipid 
bilayers, and mammalian cells have several types urea transporter (UT) that facilitate the 
transport of urea down a concentration gradient through the plasma membrane (108). 
Each UT has 10 predicted transmembrane helices, except for UT-A1, which has 20 
transmembrane domains arising from two tandem UT domains (164). The region in the 
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first and the last five transmembrane helices are highly homologous, and each 5 
transmembrane repeat contain a conserved motif with the following sequence: 
LPXXTXPF. This motif is thought to be critical for urea permeation (164). 
Two gene families encode for the urea transporters in mammals: Slc14a1 and 
Slc14a2 (171). The Slc14a2 gene encodes the UT-A family, whereas the Slc14a1 gene 
encodes the UT-B family. There are 6 major isoforms of the UT-A family, each with a 
distinct expression profile, which are derived by alternative splicing of the same mRNA 
and alternative promoter of the same gene (47). AVP regulates UT-A1 (179), which is 
expressed in the apical plasma membrane of principal cells of the IMCD and is involved 
in the reabsorption of urea in the IMCD. Two distinct forms of UT-A1, 97 kD and 117 kD, 
have been characterized that arise due to different state of glycosylation of the protein 
(12). UT-A2 (55 kD) is expressed in the liver and the kidney (143), where UT-A2 is involved 
in the transport of urea across the apical membrane into the luminal space of the thin 
descending limb of the nephron (158). UT-A3 is expressed in the IMCD (194), and similar 
to UT-A1 it has two forms, a 44 kD form and a 67 kD form. In rat IMCD, UT-A3 localizes 
to the apical membrane and intracellular vesicles (194), whereas in mouse IMCD UT-A3 
is localized in the basolateral membrane (184). UT-A4 has only been found in rat kidney 
medulla (83), and its function currently remains unknown. Both UT-A5 and UT-A6 are 
expressed in non-renal tissues: UT-A5 in the testis (42) and UT-A6 in the colon (182). UT-
B is expressed in several tissues, including in the basolateral and apical membranes of 
the descending vasa recta (195).   
Cellular mechanisms in the regulation of urea transporters 
UTs play an important role in the urine-concentrating mechanism in the kidney, 
and a loss of UT in mammals result in some form of urine-concentrating defect (45, 173). 
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Urea transportation, therefore, is highly regulated and a major mode of this regulation 
occurs via the cellular regulation of the UTs.  
Regulation of UT-A1 
UT-A1 is critical for basal urine-concentrating ability, as shown in mice where 
transgenic expression of UT-A1 in UT-A1/A3 double knock out mice corrects the urine-
concentrating defect in these animals (92). Perfusion of rat IMCD with AVP rapidly 
increases the facilitated urea permeability (141, 170); the way AVP induces this change 
is by increasing the trafficking of UT-A1 to the apical membrane (143). AVP has also been 
shown to increase the apical membrane accumulation of UT-A1 in the IMCD of Sprague-
Dawley rats (89). Phosphorylation is a major post translational modification of UT-A1 that 
influences its membrane trafficking. Phosphorylation of serine-486 and serine-499 by PKA 
increases the membrane accumulation of UT-A1(11) and both of these phospho forms of 
UT-A1 primarily localize to the apical membrane. Additionally, UT-A1 is also 
phosphorylated at serine-494 by PKC, which acts in concert with PKA to increase the 
insertion of UT-A1 in the apical membrane (9). AMP-activated protein kinase also 
increases the phosphorylation of UT-A1, but in an AVP-independent manner (91). The 
accumulation of UT-A1 in the apical membrane is reduced by 14-3-3 proteins, which bind 
and target UT-A1 for ubiquitination and degradation (41), thereby ultimately reducing urea 
transport in the IMCD.  
The IMCD expresses two isoforms of UT-A1, a more abundant 97 kD form and a 
less abundant 117 kD form (12, 193). The abundance of the 117 kD isoform is regulated 
and increases when medullary urea concentration falls, such as during intake of a low 
protein diet (193), and decreases during high medullary urea concentration, such as 
during anti-diuresis and high protein diet intake (193). However, the expression of the 117 
kD is not regulated by circulating AVP (193). 
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Regulation of UT-A2 
UT-A2, expressed in the thin descending limbs of the kidney nephron, corresponds 
to the COOH-terminal 397 amino acids of the UT-A1 protein, and is a product of alternative 
transcription of the parent Slc14a2 gene, wherein the transcription of UT-A2 begins at 
exon 13 located 200 kb downstream of exon 1 (133). Both the transcript and protein level 
of UT-A2 are elevated by chronic treatment with AVP (202). In mice, UT-A2 is required to 
maintain a high medullary urea concentration when urea supply to the kidney is restricted, 
such as during low protein diet (196), although UT-A2 is dispensable for inner medullary 
urea accumulation under basal conditions.     
Regulation of UT-A3 
UT-A3 is expressed in the IMCD, predominantly in the basolateral membrane of 
IMCD in mice (184, 194) and is transcribed from exons 1-12 of Scl14a2 gene (133). UT-
A3 undergoes phosphorylation in a cAMP-dependent manner, and phosphorylation of the 
protein increases its presence in the plasma membrane (10). Additionally, AVP acutely 
increases the accumulation of UT-A3 in the basolateral membrane of MDCK cells (185), 
thereby increasing urea flux in these cells. Although UT-A1 is required for the basal urine-
concentrating ability in mice, UT-A3 is required for the AVP-mediated increase in urea 
permeability of the IMCD (92). 
Regulation of UT-B 
Within the kidney, UT-B is expressed in the descending vasa recta, where it plays 
an important role in the recycling of urea to maintain the osmotic gradient of the medulla. 
UT-B is also expressed in the red blood cells and humans lacking this transporter develop 
a urine-concentrating defect (173). Mice lacking UT-B develop a severe urine-
concentrating defect under basal conditions (207) due to impairment of urea recycling in 
the vasa recta. The concentrating defect in UT-B-null mice is more severe than that in UT-
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A2-null mice, suggesting that the countercurrent exchange of urea between ascending 
and descending vasa recta are more important in the entrapment of medullary urea than 
the transfer of urea from the vasa recta to the thin limbs (43). Although UT-B deletion in 
mice does not affect the expression of the IMCD UTs, there is an increase in the 
expression of UT-A2 in the mice (90). Short-term treatment with AVP in Brattleboro rats 
reduces UT-B expression, whereas long-term treatment with AVP increases UT-B 
expression (157).  
As apparent from the discussion above, renal urea handling dictates the urine-
concentrating ability of the kidney, and a major regulatory arm of the renal urea handling 
is the cellular regulation of the urea transporters of the kidney. Even after decades of 
studying these transporters, there are gaps in the understanding of the cellular and 
molecular machineries involved in the regulation of these urea transporters. In order to 
better understand these cellular events, it is, therefore, important to properly identify and 
characterize molecules and proteins involved in the regulation of renal urea handling. 
  
20 
 
Role of hypothalamus and neurohypophysis in the regulation of water balance 
An important aspect of water homeostasis is to be able to sense the changes in 
plasma osmolality. Neurons in the organum vasculosum laminae terminalis (OVLT) (27, 
201), supraoptic and paraventricular nuclei of the hypothalamus (107, 118) have been 
identified to be involved in osmosensing. It has been proposed that an increase in plasma 
osmolality, such as during water deprivation, causes membrane depolarization via the 
activation of calcium channels (17, 110). The nature of the actual stimulus that causes 
these changes in membrane polarization are unknown, but a role of the mechanical stretch 
receptors called transient receptor potential vanilloid in osmosensing has been proposed 
(110). The neurons involved in osmosensing undergo shrinkage in the face of 
hyperosmolality, and it is proposed that this reduction in cell volume, as well as 
Angiotensin II (154), allows these cells to stimulate thirst and AVP release.  
The brain regions identified to be associated with the perception of thirst are the 
anterior wall of the third ventricle, the anterior cingulate, parahippocampal gyrus, insula, 
and the cerebellum (38). These regions of the brain are known to be associated with higher 
behavioral functions, explaining why thirst is physiologically connected to complex social 
and emotional behaviors such as motivation. The OVLT senses hyperosmolality and in 
turn relay the stimuli to  the insula and cingula through the thalamic nuclei, initiating the 
sensation of thirst (72), which is quenched immediately upon drinking. Very recently, other 
peripheral sodium sensors in the gastrointestinal tract and liver have been identified that 
are thought to participate in the thirst mechanism (103). 
AVP is a major peptide hormone that regulates numerous physiological functions, 
including the regulation of water balance. AVP is a nonapeptide that  is synthesized from 
a 39-amino acid-long pre-pro hormone (100) in the magnocellular cell bodies of the 
supraoptic and paraventricular nuclei of the posterior hypothalamus. AVP then binds to 
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the carrier protein called neurohypophysin and is transported to the axonal terminals of 
the magnocellular neurons of the posterior pituitary gland (33), where it temporarily stored. 
It takes almost 2 hours for the complete synthesis and storage of AVP, and the half-life of 
AVP is around 30 minutes (79). AVP mediates its affect by binding to V1, V2, V3, and 
oxytocin receptors located in target organs. The V1 receptor is expressed in the 
vasculature, and binding of AVP to V1 receptor results in vasoconstriction. The V3 
receptor is expressed in the pituitary gland. V2 receptors are expressed in the distal 
tubules and collecting ducts of the kidney, where the binding of AVP stimulates the 
increase in the water permeability of the CD and allows concentration of urine (33).  
Two major stimuli for AVP secretion into the circulation are reduced blood volume 
and hypertonic plasma, with the latter being the more sensitive stimulus (35). The osmolar 
threshold of AVP release is almost 5 mOsm/kg lower than the threshold for thirst, allowing 
AVP to regulate urinary water excretion without the need to drink constantly (33). Apart 
from osmotic stimulation, the release of AVP is also regulated by several non-osmotic 
stimuli, such as Angiotensin II, norepinephrine, dopamine, pain, hypoxia, and acidosis 
(106). Altogether, the stimulation of the osmosensing mechanism of the brain triggers the 
thirst mechanism and release of AVP to allow conservation of water.  
Maintenance of water homeostasis is a complex process that involves the 
integrative action of the hypothalamus, neurohypophysis, and the kidney. As discussed 
so far, the regulation of water balance by these organs rely largely on cellular events such 
as protein trafficking. For example, an important regulatory step that determines the 
kidney’s ability to concentrate urine is the endocytic recycling of AQP2 water channel to 
the apical membrane of the tubular epithelium. Once in the apical membrane, AQP2 
allows entry of water from the tubular fluid into the principal cells, thereby allowing the 
kidney to reabsorb water. Similar to AQP2, epithelial cells of the kidney’s nephrons modify 
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the composition of urine by selective reabsorption or secretion of solutes and water with 
the help of various other channels and transporters located on their membranes. A key 
means of regulating urine composition is via the regulation of the presence and abundance 
of these channels and transporters on the membrane of the epithelial cells (205). Under 
steady-state conditions, expression of many of the channels and transporters on the 
membrane represents the culmination of a very dynamic process, wherein constitutive 
recycling works in balance with post-synthetic membrane localization, endocytosis and 
lysosomal degradation (18, 167). Therefore, it is important to understand the intricacies of 
the endocytic recycling of channels and transporters in the kidney epithelium, and how 
endocytic recycling plays a role in the adjustment of urine composition and thus water 
homeostasis.   
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Endocytic recycling 
Endocytic recycling is a cellular process that regulates the composition of the 
plasma membrane by controlling the uptake and insertion of proteins and other molecules 
from or into the plasma membrane (61). As discussed in the previous sections, this cellular 
process is extremely crucial in the regulation of the renal urine-concentrating mechanism. 
The amount of channels and transporters in the appropriate plasma membrane of the 
tubular epithelium determines the rate and quantity of water and solute reabsorption, and 
therefore, endocytic recycling is crucial for normal physiological processes, such as 
maintenance of water balance.  
Cellular events during endocytic recycling 
Endocytic recycling regulates the amount of materials extracted from the plasma 
membrane by endocytosis and the amount that is returned to the plasma membrane. 
Plasma membrane proteins can be internalized in the cell by either clathrin-dependent or 
–independent endocytosis (28). Regardless of how proteins are internalized into the cells, 
the endocytosed proteins arrive into the early endosome first. The fate of the internalized 
proteins in the cell is, therefore, ultimately determined once it enters the early endosome 
(81). Inside the early endosome, the internalized proteins undergo sorting, while the 
endosome starts generating membrane tubules to pass the internalized cargo to the 
recycling compartments. Depending on the nature of the internalized protein and the state 
of the cell, the protein may be trafficked to the lysosome for degradation. In most 
instances, the internalized proteins pass down to the endocytic recycling compartment 
(ERC) from the early endosome before going back to the plasma membrane (121). It has 
been proposed that during the early-endosomal maturation the tubules emerging from the 
early endosome forms the ERC, while the main body of the early endosome becomes 
what is known as multi-vesicular body (MVB) (155). The ERC has been found to be 
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localized near the microtubule organizing center and the Golgi apparatus. Trafficking from 
the ERC to the plasma membrane involves a number of different routes and the nature of 
the transition primarily depends on the type of internalized protein and the proteins 
regulating the endocytic recycling (61).  
Regulation of endocytic recycling 
The sorting and trafficking of cargo during endocytic recycling is regulated by 
various proteins: Rab- and Arf-GTPases and their effectors; Eps15 homology domain-
containing (EHD) proteins 1-4. These regulators of endocytic recycling serve as 
scaffolding proteins, and regulate the tubulation of the membranes and regulate the 
activity of motor proteins and membrane fission proteins (61). Several studies have 
documented the putative roles of the Rab-GTPases and their effector protein in the 
trafficking of channels and transporters in the collecting duct (29, 176). In particular, large 
scale proteomic analysis of AQP2-containing vesicles from the principal cells have been 
shown to contain many of these Rab proteins (5). Very recently, similar analysis of UT-
A1-containing vesicles have also revealed the presence of Rab-GTPases (22), suggesting 
a potential role of these endocytic regulators in the trafficking of AQP2 and UT-A1. 
Although these studies have only characterized the Rab proteins, limited to no data on the 
roles of EHD proteins on the trafficking of renal channels and transporters is present. In 
recent years, the importance of EHD proteins in the regulation of endocytic recycling have 
emerged and the overall aim of this dissertation is focused to elucidate the novel role of 
these proteins in the kidney. The following section discusses these EHD proteins and what 
is currently known about their cellular and physiological roles. 
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EHD proteins 
The C-terminal Eps15 homology domain-containing (EHD) proteins emerged as 
important regulators of endocytic recycling almost a decade after the discovery of the Rab-
GTPases. Mammals express four members of EHD proteins: EHD1-4 (135). Through their 
interactions with Rab proteins these EHD proteins regulate endocytic recycling (212). 
Structural features and cellular functions of EHD proteins 
EHD proteins consist of 534-543 amino acid residues. The full-length EHD protein 
contains two helical regions, a conserved ATP-binding domain, a linker region, and a C-
terminal EH domain (181). The function of these EH domains is to mediate highly specific 
protein-protein interactions between the EH domain of EHD proteins and the tripeptide 
motif asparagine-proline-phenylalanine of the interacting partner (168). The degree of 
sequence homology of the EH domains among the EHD proteins range from 53.0% to 
81.5% (135). In the cytoplasm, EHD proteins bind to ATP and undergo dimerization, which 
allows the EHD proteins to bind to and associate with membrane tubular proteins. The 
hydrolysis of ATP of the EHD proteins destabilizes the vesicle membrane and results in 
membrane scission.  
Expression profile and physiological functions of EHD proteins 
Tissue distribution analysis of the EHD proteins has revealed abundant expression 
across tissues, including the heart (63), brain (26), kidney (58), and in cell types of various 
origins (180). Although recent studies involving EHD-null mice have started to highlight 
the importance of these proteins in different physiological processes (4, 31, 56, 160), very 
little is known regarding the precise functions of EHD proteins in vivo. 
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Emerging understanding of the physiological roles of EHD proteins 
In recent years, EHD proteins have emerged as important regulators of endocytic 
recycling of membrane proteins. Although reports on the specific functions of EHD 
proteins in the body is currently limited, studies with global EHD knockout mice have 
started shedding some light on the understanding of the physiological roles of EHD 
proteins. Both EHD1 and EHD4-null mice develop small testis (57, 160), indicating a role 
of these EHD members in the male germ cell development. Additionally, EHD proteins 
have been shown to be important in regulating cardiac membrane protein trafficking via 
their interaction with ankyrin-B (63). In particular, EHD3 has been demonstrated to be 
involved in the anterograde trafficking of Na/Ca exchanger and Cav1.2 in ventricular 
mycocytes (31), as well as T-type Ca channels in the atria (32). These studies have shown 
that EHD3 regulates cardiac membrane excitability in mice. 
Both EHD3 and EHD4 regulate the trafficking of internalized proteins in the early 
endosomes (136, 178). In HeLa cells, deletion of EHD4 results in enlargement of the early 
endosomal compartments, with proteins destined for degradation being aggregated in the 
early endosome (178). This study has demonstrated that EHD4 is required for the exit of 
cargo from the early endosomes to the recycling and late endosomes. Although EHD3-
null mice do not develop any pathological phenotype (56),  a recent study with mice lacking 
both EHD3 and EHD4 have shown that the combined deletion of both these members 
result in a glomerular pathology called renal thrombotic microangiopathy (56). This report 
also demonstrated that in EHD3-null mice, there is a compensatory functional upregulation 
of EHD4 within the glomerular endothelial cells, where the expression of EHD4 is usually 
low, suggesting a potential role of EHD4 in the renal microvasculature. Although this report 
elegantly highlighted an important role of EHD4 in the renal microvasculature, the specific 
role of EHD4 in the kidney tubule remains unknown. While the proteomic database of inner 
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medullary collecting duct cells maintained by the NIH Epithelial Systems Biology 
Laboratory shows hits for EHD4 (http://helixweb.nih.gov/ESBL/Database/index.html; last 
accessed on 10/10/2016), no information is available on the exact role of EHD4 in these 
cells. Accordingly, the main focus of this dissertation is to elucidate the physiological role 
of EHD4 in the kidney.  
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Objectives of this dissertation 
Endocytic trafficking of membrane proteins is an important cellular event that 
determines the kidney’s ability to concentrate urine and thus regulate water homeostasis 
(46). As described above, the fate of internalized proteins are determined in the early 
endosome and one of the important regulators of early endosomal activity is EHD4 (178). 
The study of George et. al. (56) indicate that EHD4 is able to compensate for the loss of 
EHD3 in mice, but the exact role of EHD4 in the kidney remains unknown. Based on the 
expression profile of EHD4 in the collecting duct cells derived from the aforementioned 
proteomic database, the aim of this dissertation, therefore, was to determine the 
roles of EHD4 in the kidney, particularly in the regulation of water homeostasis. This 
dissertation will test the hypothesis that EHD4 regulates the formation and 
composition of urine in mice by regulating channel and transporter membrane 
abundance in the collecting duct. As such, the study is divided into three broad aims 
and the objectives of each of these aims are as follows: 
Aim 1: To evaluate the physiological role of EHD4 in the regulation of urine formation and 
composition at the whole body level. 
Aim 2: To investigate the role of EHD4 in the regulation of AQP2 trafficking in principal 
cells of the collecting duct. 
Aim 3: To determine the role of EHD4 in the regulation of renal urea handling. 
Each aim will be presented in the one of the following chapters, with each chapter 
containing an introduction explaining the rationale for the Aim, the methods used to study 
the Aim, the results generated, and a discussion of the findings. At the end of the chapters, 
a final comprehensive Discussion section is presented to provide a cohesive 
amalgamation of the findings of all three Aims.  
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CHAPTER I: ROLE OF EHD4 IN THE REGULATION OF 
URINE FORMATION AND COMPOSITION 3 
  
                                                
3 The material presented in this chapter was previously published: Rahman, S.S., Moffitt, A. E. J., 
Trease, A., Foster, F. W., Storck, M., Band, H., Boesen, E. I. EHD4 is a novel regulator of urinary 
water homeostasis. FASEB J. (2017)  
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Introduction 
Recently, the study of EHD knockout mice has begun to reveal key physiological 
processes to be regulated by these proteins, such as EHD3-regulated maintenance of 
cardiac membrane excitability (31) and EHD1- and EHD4-dependent development of 
testes size and spermatogenesis in male mice (57). Moreover, it has been reported (56) 
that mice lacking both EHD3 and EHD4 develop renal thrombotic microangiopathy-like 
glomerular lesions in association with reduced glomerular VEGFR2 expression, signifying 
the importance of these proteins in glomerular filtration barrier homeostasis. This study 
(56) also showed that mice lacking only EHD3 do not develop such renal pathology due a 
compensatory increase in EHD4 within the glomerular endothelium. Interestingly, 
glomerular EHD4 staining was very low under baseline conditions in wild-type mice, and 
appeared restricted to endothelial cells (56). Although this previous study indicated an 
important role for EHD3/4 in the glomerulus, whether EHD4 might play a role in trafficking 
of proteins in the tubular and collecting duct system has remained unanswered. 
Additionally, the NIH Epithelial Systems Biology Laboratory’s proteomic databases 
(http://helixweb.nih.gov/ESBL/Database/index.html; last accessed on 10/10/2016) of 
inner medullary collecting duct cells and mpkCCDc14 cells (an immortalized mouse cortical 
collecting duct cell line), revealed EHD4 expression in the collecting duct, suggesting that 
EHD4 may play one or more additional roles in the kidney. However, to date, the role of 
EHD4 per se in normal renal physiology has not been directly addressed. The aim of this 
chapter, therefore, was to determine the roles of EHD4 in the kidney, particularly in 
the regulation of water homeostasis given the proteomics-based evidence of 
collecting duct EHD4 expression.  
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Methods 
Animals 
All animal studies were approved in advance by the Institutional Animal Care and 
Use Committee at the University of Nebraska Medical Center. Experiments were 
conducted on 12 to 18-week old male and female Ehd4-/- (EHD4-KO) mice (n = 6 for male; 
n = 5 for female), generated as described previously (56) on the C57Bl/6 background. 
Age-matched male and female C57Bl/6 (WT) mice (n = 9 for male; n = 4 for female) were 
used as control mice (Jackson Laboratories, Bar Harbor, ME). The animals were housed 
in cages maintained at room temperature, 60% humidity with a 12/12 hour light/dark cycle. 
The mice were given free access to normal rodent chow (7012, Harlan Teklad, Madison, 
WI) and drinking water except as described below. 
Baseline urinary analysis 
Animals were placed in individual metabolic cages for 24 hours for comparison of 
baseline physiological parameters, specifically food intake, water intake and urine output. 
Animals had free access to food and water during the experiment and were returned to 
their home cage at the end of the experiment. “Spot” urine samples were also collected 
following spontaneous voiding. Urine samples were stored at -80 °C until analysis. Urine 
osmolality was analyzed by freezing point depression using an osmometer (model 3250, 
Advanced Instruments, Norwood, MA) and plasma osmolality using a vapor pressure 
osmometer (Model 5520, Wescor, Logan, UT). Electrolyte concentrations of the samples 
were measured using Ion Selective Electrode technology (MEDICA EasyElectrolytes, 
Medica Corporations, Bedford, MA). AVP and creatinine concentrations were measured 
according to the manufacturer’s instructions using a Arg8-Vasopressin ELISA kit (Enzo 
Life Sciences, Farmingdale, NY)  and QuantiChrom™ Creatinine assay kit (Bioassay 
Systems LLC, Hayward, CA) respectively. 
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Response to acute water loading 
Each mouse underwent intra-peritoneal (I.P.) injection of 2 ml sterile water and 
was placed in a metabolic cage for 6 hours during which food and water were withheld 
(55). Urine samples were collected hourly for 6 hours and stored at -80 °C until analysis 
of osmolality, as described above. 
Response to 24-h water restriction 
Male WT and EHD4-KO mice (n = 6-7 in each group) were placed in individual 
metabolic cages with access to food and water. The mice were allowed to acclimate to the 
cage for the first 24 hours, followed by a 24 hour baseline collection period, then a 24 hour 
water restriction period during which no drinking water was provided. During these 
periods, urine was collected under paraffin oil (to prevent evaporation), then stored at -80 
oC for later analysis of osmolality, as above. To test for compensatory changes in EHD 
protein expression in response to water restriction, female EHD4-KO mice underwent a 
similar protocol except that one group continued to receive access to water throughout the 
second 24 hour collection period (euhydrated or EU EHD4-KO mice, n = 4) and the other 
group was water-restricted (WR EHD4-KO mice, n = 6). At the end of the EU or WR period, 
animals were sacrificed to collect renal tissues for immunoblotting and 
immunofluorescence analysis.  
Response to acute amiloride injection 
As a test of epithelial sodium channel (ENaC) activity in vivo, EHD4-KO and WT 
mice received I.P. injections of amiloride (5 mg/kg) (EMD Chemicals, Inc., San Diego, CA) 
and an equivalent volume of vehicle (polyethylene glycol) (163). Mice were placed in 
metabolic cages immediately after the injection. Food and water were withheld, and urine 
was collected over a 4-h period. The difference in urine volume and sodium excretion 
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between vehicle and amiloride treatments for each mouse was calculated and compared 
between groups. 
Response to acute furosemide injection 
As a test of Na-K-2Cl cotransporter 2 (NKCC2) activity in vivo, EHD4-KO and WT 
mice received I.P. injections of furosemide (40 mg/kg) (Hospira Inc., Lake Forest, IL) (86) 
and an equivalent volume of vehicle (polyethylene glycol) on two separate occasions. 
Immediately after the injections, the mice were placed in metabolic cages, food and water 
were withheld, and urine was collected for a 4-hour period. The difference in urine volume 
and sodium excretion between vehicle and furosemide treatments for each mouse was 
then calculated and compared between groups. 
Tissue homogenate preparation 
Mice were sacrificed by thoracotomy under isoflurane anesthesia, accompanied 
by cardiac puncture and exsanguination to allow for blood and tissue collection. Plasma 
was obtained upon centrifugation of heparinized whole blood, while the other tissues were 
snap-frozen in liquid nitrogen and stored at -80 °C. One kidney of each mouse was 
dissected into inner medulla (IM), outer medulla (OM) and cortex, while the other was cut 
longitudinally for histological analyses and immersion-fixed in 10% neutral buffered 
formalin then paraffin-embedded. Additional WT mice were used for isolation of nephron 
segments for EHD4 immunoblotting. The Percoll gradient centrifugation method was used 
to obtain separate preparations of proximal tubules and distal tubules from a collagenase-
digested cortical tubular suspension, following methods described previously with minor 
modifications  (199, 200). Medullary thick ascending limbs (mTALs) were freshly prepared 
from the inner stripe of the outer medulla by a minor modification of the method described 
previously (208). Inner medullary collecting ducts (IMCDs) were isolated from the renal 
inner medulla using a modified version of the protocol described previously (94). 
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Hypothalamic tissue was collected and processed as described by Nørregaard et al. (147) 
and was analyzed for EHD1 and EHD3 expression levels by Western blotting. Renal 
tissues were homogenized in kidney extraction buffer (KEB: 50 mM Tris pH 7.4, 0.1 mM 
EDTA, 0.1 mM EGTA, 10% glycerol, pH 7.4; 200 µl for each IM sample or 10X w/v for OM 
and cortex) and a cocktail of protease inhibitors (final concentrations: 1 mM 
phenylmethylsulfonyl fluoride, 2µM Leupeptin [Sigma-Aldrich, St. Louis, MO], 1 µM 
Pepstatin A [Sigma-Aldrich, St. Louis, MO], a 1:1000 dilution of 0.1% Aprotinin [Sigma-
Aldrich, St. Louis, MO], 14.3 mM 2-mercaptoethanol and 10 µl/ml Phosphatase inhibitor 
cocktail [Sigma-Aldrich, St. Louis, MO]). Supernatant from the homogenates was collected 
after centrifugation at 10,000 g for 5 minutes at 4 °C and protein concentration of each 
sample was measured using the Bradford method (Bio-Rad protein assay kit, Bio-Rad 
Laboratories, Hercules, CA). Homogenates were stored at -80 °C until further analyses 
were carried out. 
Quantitative immunoblot analysis 
Expression levels of different proteins in the renal tissues were analyzed by 
resolving extracts on SDS-PAGE, followed by subsequent electric transfer to 
polyvinylidene difluoride (PVD) membrane (Bio-Rad). The PVD membranes were blocked 
with Odyssey® Blocking Buffer (LI-COR® Biosciences, Lincoln, NE) for 1 hour and then 
incubated overnight in an optimized concentration of the respective primary antibody at 
4°C. After multiple washes in 10 mM Tris-Buffered Saline and 0.05% Tween-20 (TBST), 
the membranes were incubated in appropriate fluorophore-conjugated secondary 
antibodies (1:10000 dilution, Alexa Fluor® conjugates, ThermoFisher Scientific, Rockford, 
IL) and the membranes were scanned, viewed and analyzed with an Odyssey Infra-red 
Imaging System. Beta-actin (1:5000 dilution, Sigma-Aldrich, St. Louis, MO) was used as 
a loading control. The following primary antibodies were used: rabbit anti-EHD1, anti-
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EHD2, anti-EHD3 and anti-EHD4 (1:1000 dilution, generated as described previously) 
(58); rabbit anti-EHD4 (ab-83859, 1:1000 dilution, AbCam, Cambridge, MA); goat anti-
AQP2; (sc-9882, 1:2000 dilution, Santa Cruz Biotechnology, Dallas, TX);  rabbit anti-
NKCC2 (AB-3562P, 1:1000 dilution, EMD Millipore, Cincinnati, OH); rabbit anti-phospho-
NKCC1-Thr212/Thr217 (ABS1004, 1:1000 dilution, EMD Millipore Corporation); rabbit 
anti-αENaC (AB-3530P, 1:500 dilution, EMD Millipore Corporation). 
Immunofluorescence staining and histological analyses of kidneys 
Paraffin-embedded kidney sections from WT and EHD4-KO mice (n = 3-4 per 
group; 3-5 images per IM section) were de-paraffinized with xylene and then dehydrated 
with absolute ethanol. The sections were subjected to rehydration by serial immersion in 
90, 80 and 70% ethanol followed by antigen retrieval by heating in citrate buffer for 20 min. 
After washing in 1X PBS and blocking in 5% FBS in 1X PBS for 1 hour, the sections were 
incubated with primary antibodies against AQP2 (1:2000 dilution) overnight at 4 °C. 
Fluorescently-tagged secondary antibodies (1:500 dilution) were added for 1 hour, 
followed by washing and addition of mounting solution containing 4',6-diamidino-2-
phenylindole (DAPI) (VectaShield, Vector Laboratories, Burlingame, CA). The sections 
were imaged using a confocal microscope (Leica TCS SP8, Leica Microsystems, Buffalo 
Grove, IL) at 60X magnification. Apical membrane abundance of AQP2 was quantified by 
measuring the pixel intensities of the channels within a consistent defined region of the 
apical membrane using the image analysis tool ImageJ (freely downloaded from 
https://imagej.nih.gov/ij/). The analysis was performed in a blinded manner in 3-5 images 
of inner medulla in each mouse. In addition, hematoxylin and eosin, Masson’s trichrome 
and Periodic Acid-Schiff-stained kidney sections were viewed by light microscopy and 
general morphology was evaluated for qualitatively in a blinded manner. 
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Statistical analyses 
Statistical analyses were performed using GraphPad Prism 6 for Windows 
(GraphPad Software Inc., La Jolla, CA). All data are shown as the mean ± SEM. Results 
from experiments yielding a single data point per group were analyzed by Student’s t-test 
or one-way ANOVA, or two-factor ANOVA to test for main effects of genotype and sex. 
Experiments yielding repeated measures were examined by two-way ANOVA for repeated 
measures. Bonferroni correction was used for post-hoc analysis and a P value < 0.05 was 
considered statistically significant. 
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Results 
Expression pattern of EHD4 varies across nephron segments 
Western blot analysis confirmed expression of EHD4 in freshly isolated mouse 
glomeruli, proximal and distal tubular cells, IMCDs, mTALs (Fig. 1). The highest 
expression of EHD4 in nephron segments studied was observed in the IMCD-enriched 
nephron preparation. Cross-contamination of the other preparations with collecting ducts 
was checked by blotting for AQP2, with a positive signal present in the distal tubular 
preparation, IMCD and inner medulla but absent from proximal tubules, mTALs and 
glomeruli.  
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Figure 1: Expression profile of EHD4 across nephron segments.  
Immunoblot of EHD4 in enriched nephron segments from a C57Bl/6 mice (n = 
1). An equal amount of protein was loaded from homogenates of glomeruli, 
proximal tubular cells (PTC), distal tubular cells (DTCs), mTAL, IMCD, and IM 
from WT and EHD4-KO mice. Homogenates were tested for cross-
contamination by blotting for AQP2. 
Figure 1: Expression profile of EHD4 across nephron segments 
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Deletion of EHD4 had no apparent effect on the kidney morphology in mice 
Kidneys of the EHD4-KO mice appeared to develop normally, and although light 
microscopy showed subtle differences in the amount of cytoplasm between WT and 
EHD4-KO tubular cells (blinded analyses performed by Dr. Kirk Foster), no significant 
morphological defect was observed in kidneys of EHD4-KO mice (Fig. 2). Kidney-to-body 
weight ratio was comparable between WT and EHD4-KO mice (male: 6.1 ± 0.14 for WT 
vs. 6.2 ± 0.24 mg/g for EHD4-KO mice, P = 0.77; female: 5.4 ± 0.17 for WT vs. 5.0 ± 0.25 
mg/g for EHD4-KO mice, P = 0.18).  
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Figure 2: Effect of EHD4 deletion on gross renal morphology. Representative 
hematoxylin and eosin staining of whole kidney sections and IM of female WT and 
EHD4-KO mice. Original magnification X40; scale bar = 10 μm. 
Figure 2: Effect of EHD4 deletion on gross renal morphology 
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Absence of compensatory upregulation of other EHD proteins in EHD4-KO mice 
EHD proteins have been previously reported to be upregulated during the absence 
of other EHD proteins (56). Therefore, the expressions of EHD1, EHD2, and EHD3 were 
next analyzed in the kidney of WT and EHD4-KO mice. There was no significant 
compensatory increase in the total abundance of EHD1 and EHD3 in kidneys of EHD4-
KO mice (Fig. 3A & B). EHD2 expression was too low for accurate quantification. 
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B 
Figure 3: Renal expression of EHD1 and EHD3 in the absence of EHD4. Representative 
Western blots and densitometric analysis of (A) EHD1 and (B) EHD3 in cortex, outer, and inner 
medulla of the kidney of WT and EHD4-KO mice. Graphed data are means ± SEM of n (in 
parentheses). P values were determined by unpaired t test. 
Figure 3: Renal expression of EHD1 and EHD3 in the absence of EHD4 
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EHD4-KO mice produce higher volumes of dilute urine than WT mice under baseline 
conditions 
The presence of EHD4 in IMCD and mTAL suggested a potential role in both urine 
formation and concentration. Under 24-hour baseline conditions, water intake was slightly 
(~20%) but significantly higher in EHD4-KO mice compared to WT mice (Pgenotype < 0.05; 
Fig. 4A); food intake was not significantly different between WT and EHD4-KO mice (Fig. 
4B). Notably, EHD4-KO mice produced significantly higher volumes of urine than WT mice 
(by ~140-160%; Pgenotype < 0.0001; Fig. 5A). Urine osmolality of EHD4-KO mice was almost 
50% lower than that of WT mice (Pgenotype < 0.0001; Fig. 5B). Osmolality of spontaneously 
voided “spot” urine revealed a similar significant difference (Pgenotype < 0.01; Fig. 5C). Body 
weights of WT and EHD4-KO mice were comparable (females: 23.0 ± 0.6 g in WT vs 23.4 
± 0.7 g in EHD4-KO, P = 0.65; males: 28.5 ± 2.1 g in WT vs 28.3 ± 1.6 g in EHD4-KO, P 
= 0.88). Plasma creatinine levels were not significantly different between WT and EHD4-
KO mice (males: 0.21 ± 0.04 for WT vs. 0.20 ± 0.04 mg/dL for EHD4-KO mice, P = 0.67; 
female: 0.26 ± 0.02 for WT vs. 0.25 ± 0.03 mg/dL for EHD4-KO mice, P = 0.95). Plasma 
osmolality was measured in these and in additional mice from which tissues were collected 
for analyses described below. Plasma osmolality was not significantly different between 
WT and EHD4-KO mice (Pgenotype = 0.6), or male and female mice (Psex = 0.2), nor were 
there sex differences in the impact of EHD4-KO (Pinteraction = 0.7; males: 326 ± 4 mOsmol/kg 
H2O for n = 13 WT vs. 331 ± 8 mOsmol/kg H2O for n = 10 EHD4-KO mice; female: 321 ± 
5 mOsmol/kg H2O  for WT vs. 321 ± 2 mOsmol/kg H2O for EHD4-KO mice, n = 8 in both 
groups). There was no sex differences in the effects of EHD4 gene deletion on the above 
parameters (Pinteraction > 0.05 in all cases). Accordingly, the biochemical and histological 
analyses described below were performed on either male or female mice to conserve 
tissue. 
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Figure 4: Effect of EHD4 deletion on general metabolic parameters in mice. 
Data presented are 24 h water intake (A) and food intake (B) of male and female 
EHD4-KO mice. All values are means ± SEM of n mice (in parentheses). Data 
were analyzed by 2-factor ANOVA, testing for main effects of genotypes 
(Pgenotype), sex (Psex), and the interaction between sex and genotype (Pinteraction). * 
P < 0.05 for EHD4-KO vs. WT mice of each sex, by post hoc test. 
Figure 4: Effect of EHD4 deletion on general metabolic parameters in mice 
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Figure 5: Effect of EHD4 deletion on urine formation and composition 
in mice. Data presented are 24 h urine flow (A) and urine osmolality (B) of 
male and female EHD4-KO mice. Spot urine osmolality is shown in (C).  All 
values are means ± SEM of n mice (in parentheses). Data were analyzed 
by 2-factor ANOVA, testing for main effects of genotypes (Pgenotype), sex 
(Psex), and the interaction between sex and genotype (Pinteraction). * P < 0.05 
for EHD4-KO vs. WT mice of each sex, by post hoc test. 
C 
Figure 5: Effect of EHD4 deletion on urine formation and composition in mice 
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EHD4-KO mice show an exaggerated diuretic response to an acute water load  
To further test the role of EHD4 in renal water handling independent of voluntary 
water intake, the mice were subjected to an acute water load by I.P. injection. Cumulative 
urine excretion showed that the EHD4-KO mice displayed an exaggerated response to 
water loading compared to WT mice (Pinteraction < 0.05 for both sexes; Fig. 6), and both 
male and female EHD4-KO mice had excreted almost 75% of the water load by the end 
of 6 hours whereas WT mice excreted less than 50% (Fig. 6A and B). 
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Figure 6: Response of EHD4-KO mice to an acute water load as 
compared to WT mice. Cumulative urine volume of male (A) and female (B) 
WT and EHD4-KO mice over 6 h after injection of 2 mL sterile water i.p. Data 
were compared by 2-factor repeated-measures ANOVA, testing for main 
effects of genotype (Pgenotype), time (Ptime), and the interaction between time 
and genotype (Pinteraction). * P < 0.05 for EHD4-KO vs. WT mice at the 
corresponding time-points. 
Figure 6: Response of EHD4-KO mice to an acute water load as compared to WT mice 
48 
 
Responses to 24-h water restriction are similar between WT and EHD4-KO mice 
To assess the contribution of EHD4 to the urine-concentrating mechanism, WT 
and EHD4-KO mice were subjected to 24-h water restriction. After 24-h water restriction, 
male WT and EHD4-KO mice showed a similar decline in urine flow and increases in urine 
osmolality (Pinteraction > 0.05 in both cases; Fig. 7A and 7B). However, EHD4-KO mice 
maintained significantly higher urine flow and lower urine osmolality compared to WT mice 
even after water restriction (Pgenotype < 0.05 in each case; Fig. 7).  
Although the total abundance of AQP2 did not increase in WT or EHD4-KO after 
24-h water restriction (Western blot; data not shown), the apical intensity of AQP2 
increased significantly in both the groups (Fig. 8). However, the apical intensity of AQP2 
in EHD4-KO mice was significantly lower than that in WT mice under baseline conditions 
(Fig. 8). 
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Figure 7: Response of EHD4-KO mice to 24 h water 
restriction as compared to WT mice. Urine flow (A) and 
osmolality (B) of male WT and EHD4-KO mice before and 
after 24 h water restriction.  Data were compared by 2-
factor repeated-measures ANOVA, testing for main 
effects of genotype (Pgenotype), water restriction (Pwater 
restriction), and the interaction between water restriction and 
genotype (Pinteraction). Graphed data are means ± SEM of 
n mice (in parentheses). *P < 0.05 for EHD4-KO vs. WT 
mice at the corresponding time points.
Figure 7: Response of EHD4-KO mice to 24 h water restriction as compared to WT mice
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WT 
EHD4-KO 
Figure 8: Changes in cellular localization of AQP2 in EHD4-KO 
mice before and after 24 h water restriction as compared to WT 
mice. Representative immunofluorescent images and blinded 
quantification of the pixel intensity of AQP2 in the apical membrane 
of principal cells in the IM of male WT and EHD4-KO mice before 
and after 24 h water restriction. Scale bars, 10 μm. Data were 
compared by 2-factor repeated-measures ANOVA, testing for main 
effects of genotype (Pgenotype), water restriction (Pwater restriction), and the 
interaction between water restriction and genotype (Pinteraction). 
Graphed data are means ± SEM of n mice (in parentheses). *P < 
0.05 for EHD4-KO vs. WT mice at the corresponding time points.
Figure 8: Changes in cellular localization of AQP2 in EHD4-KO mice before and after 24 h water
restriction as compared to WT mice 
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Anti-diuretic responses during 24-h water restriction are independent of EHD proteins 
To determine whether there was a compensatory increase in other EHDs during 
water restriction in EHD4-KO mice, female EHD4-KO mice were subjected to either EU 
conditions or water-restricted conditions for 24 hours (Fig. 9). Immunoblots of EHD1, 
EHD2 and EHD3 in renal cortex, OM and IM showed similar expression of these proteins 
in both EU and WR EHD4-KO mice (Fig. 10 A-C). 
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Figure 9: Comparison of antidiuretic responses of EU 
and WR female EHD4-KO mice. Antidiuretic responses to 
24 h water restriction were evaluated in terms of changes 
in urine flow and osmolality. All mice received access to 
water on the baseline day, whereas only EU (n = 4), not 
WR (n = 6), EHD4-KO mice received water on experimental 
day. Data were compared by 2-factor repeated-measures 
ANOVA, testing for main effects of experimental group 
(Pgroup), water restriction (Pwater restriction), and the interaction 
between water restriction and group (Pinteraction). Graphed 
data are means ± SEM of n mice (in parentheses). 
Figure 9: Comparison of antidiuretic responses of EU and WR female 
EHD4-KO mice 
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Figure 10: Comparison of 
expressions of EHD1, 2, 
and 3 in EU and WR female 
EHD4-KO mice. 
Representative Western blots 
and densitometric analysis of 
(A) EHD1, (B) EHD2, and (C) 
EHD3 in the renal cortex, OM, 
and IM tissues of EU and WR 
EHD4-KO mice collected at 
the end of the experimental 
day. All mice received access 
to water on the baseline day, 
whereas only EU (n = 4), not 
WR (n = 6), EHD4-KO mice 
received water on 
experimental day. Please 
note that renal cortex, OM, 
and IM tissues were blotted 
separately, and data for each 
region were normalized to the 
mean for EHD group. The 
mean densitometric data for 
each region is shown on a 
single graph for ease of 
presentative but comparisons 
of relative expression 
between different regions of 
the kidney cannot be made 
from these data. All data are 
means ± SEM of n mice (in 
parentheses). P  values were 
determined by unpaired t test.
Figure 10: Comparison of expressions of EHD1, 2, and 3 in EU and WR female EHD4-KO mice 
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Hypothalamic expression of EHDs 
To begin to address whether the polyuric phenotype observed in the EHD4-KO 
mice could also involve a central component, since the EHD4-KO mouse used is a global 
knockout, hypothalamic tissue were blotted for EHDs. EHD4 was found to be expressed 
in the hypothalamus (Fig. 11A), as was EHD1, whose expression was significantly 
upregulated in EHD4-KO mice (Fig. 11B). EHD3 was also expressed in the hypothalamus 
but no difference in expression was observed between WT and EHD4-KO mice (Fig. 11C). 
Baseline plasma osmolality of EHD4-KO and WT mice was found to be comparable (Fig. 
12A). Despite EHD4-KO mice having increased urine volumes, their 24 hour urinary AVP 
excretion, an indirect index of circulating AVP, was comparable to that of WT mice (Fig. 
12B). 
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Figure 11: EHDs are expressed in the hypothalamus. Western 
blot analysis of hypothalamic expression of EHD4 (A) in a WT mouse 
and EHD1 (B) and EHD3 (C) in WT and EHD4-KO mice. Data were 
compared by unpaired t test and are means ± SEM of n mice (in 
parentheses). 
Figure 11: EHDs are expressed in the hypothalamus 
56 
 
  
A 
B 
Figure 12: EHD4 deletion does not affect plasma 
osmolality or urinary AVP. (A) Plasma osmolality of 
female WT and EHD4-KO mice. (B) Urinary AVP 
excretion rate in male WT and EHD4-KO mice. Data 
were compared by unpaired t test and are means ± 
SEM of n mice (in parentheses). 
Figure 12: EHD4 deletion does not affect plasma osmolality or
urinary AVP 
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EHD4-KO and WT mice have similar urinary sodium excretion and exhibit comparable 
responses to furosemide  
Renal sodium handling plays an important role in the urine-concentrating 
mechanism. Therefore, the effect of EHD4 deletion on the urinary sodium excretion was 
tested. There was no significant difference in urinary sodium excretion between the two 
genotypes under basal conditions (Fig. 13).  
Sodium ion concentration is an important determinant of extracellular fluid 
osmolarity. Epithelial sodium channel (ENaC), which is abundantly expressed in the 
collecting duct, finely regulates sodium reabsorption. To test if the activity of this channel 
is regulated by EHD4, amiloride was administered (a blocker of ENaC) in WT and EHD4-
KO mice. Amiloride failed to generate any natriuretic response in both WT and EHD4-KO 
mice (Fig. 14A). No significant difference in expression of the alpha subunit of the ENaC 
(ENaC) was seen between groups (Fig. 14B). 
The Na-K-2Cl cotransporter 2 (NKCC2), which is expressed by the mTAL plays a 
key role in establishing and maintaining the urinary concentrating mechanism. To test if 
the activity of this cotransporter is regulated by EHD4, WT and EHD4 KO mice were 
challenged with furosemide to block NKCC2. Responses are expressed as the differences 
in sodium excretion and urine production between acute vehicle and furosemide 
treatments. The natriuretic and diuretic responses after furosemide injection were 
comparable between the genotypes (Fig. 15A and 15B). Consistent with this finding, total 
and phosphorylated NKCC2 protein expression levels in renal outer medulla were similar 
between the two genotypes (Fig. 15C).   
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Figure 13: Effect of EHD4 deletion on sodium 
excretion. Data presented for 24 h urinary sodium 
excretion (UNaV) of WT and EHD4-KO mice. All values 
are means ± SEM of n mice (in parentheses). Data 
were analyzed by 2-factor ANOVA, testing for main 
effects of genotypes (Pgenotype), sex (Psex), and the 
interaction between sex and genotype (Pinteraction).  
Figure 13: Effect of EHD4 deletion on sodium excretion 
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Figure 14: Effect of EHD4 deletion on ENaC activity in vivo. Changes in 
(∆) urinary sodium excretion (A), calculated as the difference between values 
recorded in response to amiloride and vehicle. Data were analyzed by 2-
factor ANOVA, testing for main effects of genotypes (Pgenotype), sex (Psex), and 
the interaction between sex and genotype (Pinteraction). (B) Representative 
immunoblot and quantification of αENaC in cortex of female WT and EHD4-
KO mice. Data are presented as means ± SEM of n mice (in parentheses) 
and were analyzed by unpaired t test.
Figure 14: Effect of EHD4 deletion on ENaC activity in vivo 
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Figure 15: Effect of EHD4 deletion on NKCC2 activity in vivo. Changes in (∆) 
urine volume (A) and urinary sodium excretion (B), calculated as the difference 
between values recorded in response to furosemide and vehicle. Data were 
analyzed by 2-factor ANOVA, testing for main effects of genotypes (Pgenotype), sex 
(Psex), and the interaction between sex and genotype (Pinteraction). (C) Representative 
immunoblot and quantification of NKCC2 and pNKCC2 in OM of female WT and 
EHD4-KO mice. Data are presented as means ± SEM of n mice (in parentheses) 
and were analyzed by unpaired t test.
Figure 15: Effect of EHD4 deletion on NKCC2 activity in vivo 
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Discussion 
This chapter focused on elucidating the physiological roles of EHD4 in the kidney, 
particularly in the regulation of urine formation and composition. These findings show that 
in the kidney, EHD4 is expressed differentially across the nephron, and that global deletion 
of EHD4 in mice results in a phenotype of mild, apparently nephrogenic, diabetes 
insipidus, with EHD4-KO mice showing increased excretion of osmotically dilute urine. 
To better understand the functional roles of EHD4 in the kidney it was determined 
whether EHD4 protein was expressed in segments of the nephron important in urinary 
concentration and salt and water homeostasis. George et al. (58) had shown previously 
that EHD4 is expressed in the kidney, based on the analysis of whole kidney lysates, with 
immunofluorescence staining indicating expression by glomerular endothelial cells and 
peritubular capillaries (56). Moreover, the proteome databases constructed by the NIH 
ESBL reported EHD1-4 expression in the IMCD and EHD1 in the proximal convoluted 
tubule at the protein level as determined by mass spectrometry (104). Unfortunately, I 
have been unable to successfully immunostain the kidney sections using the currently 
available batches of rabbit polyclonal EHD4 antibodies, whether obtained from Abcam or 
custom-generated by a vendor as described previously (58). I observed via Western blot 
that EHD4 was expressed highly in the glomerulus and IMCD, with some expression in 
the distal tubular cells, mTAL and proximal tubular cells. Additionally, single tubule RNA 
sequencing data generated by Lee et. al. showed that EHD4 mRNA was highest in thin 
ascending limb (104); however, it was beyond our technical capabilities to isolate the thin 
ascending limbs to confirm protein expression by Western blot. The presence of EHD4 in 
IMCD and mTAL raised the question of whether this protein might play a role in the urinary 
concentrating mechanism. Consistent with this hypothesis, EHD4-KO mice were found to 
produce an increased volume of osmotically dilute urine compared to WT mice under 
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baseline conditions. This phenotype is suggestive of a defect in water reabsorption and 
potentially a defect in urine concentrating ability in the absence of EHD4. Although EHD4 
is abundantly expressed in the glomerulus, there was no significant difference in plasma 
creatinine level between WT and EHD4-KO mice, suggesting that EHD4 probably does 
not regulate urine formation and composition by modulating GFR. However, plasma 
creatinine is not a very precise indicator of GFR, and therefore, the role of EHD4 in 
modulating the GFR would require further analyses.   
Further supporting our hypothesis that EHD4-KO mice display altered renal water 
handling, EHD4-KO mice excreted higher volumes of urine than WT mice when 
administered with an acute intraperitoneal water load. That the response was larger in 
EHD4-KO mice compared to WT mice confirms that water handling by the kidney is 
regulated in part by EHD4. Plasma osmolality of EHD4-KO mice was similar to that of WT 
mice, suggesting that even though they have increased excretion of dilute urine, EHD4-
KO mice are able to maintain osmotic homeostasis under normal conditions. EHD4-KO 
mice consumed slightly but significantly elevated amounts of water compared to the WT 
mice. While comparison of raw volumes of water intake and urine output collected using 
metabolic cages is complicated by an unavoidable degree of urine evaporation during the 
funneling and collection process, the percentage increase in water intake (~20%) was 
much smaller than the increase in urine flow measured by metabolic cage collections 
(~140-160%). This finding can be interpreted to argue against primary polydipsia being a 
likely cause of the phenotype observed in EHD4-KO mice, although extensive additional 
experiments would be needed to rule this out definitively. This disparity in the apparent 
increase in water intake compared to urine output also suggests that mechanisms in 
addition to thirst may help to offset excess renal loss of water, possibly including enhanced 
gastrointestinal water absorption or reduced insensible water loss.  
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Excretion of small volumes of concentrated urine is a classic anti-diuretic response 
to water restriction, and EHD4-KO mice show a similar anti-diuretic response in terms of 
urine volume and urine osmolality as the WT mice. Moreover, expression of no other EHD 
protein was increased when EHD4-KO were water-restricted. Together, these data 
suggest that the renal response to water restriction occurs independently of EHD4. 
However, even after water restriction, EHD4-KO mice still displayed lower urinary 
osmolality and higher urine flow compared with WT mice, indicating that EHD4 is required 
to achieve maximal urine concentrating ability. Retention of the anti-diuretic response to 
water restriction suggests that other regulators of AVP-dependent water transport are still 
operational in EHD4-KO mice; whether this might be in part due to a functional role of the 
remaining EHD proteins (EHD1 and EHD3) expressed by the collecting duct is an 
intriguing prospect that could be addressed in future studies by collecting duct specific 
knockout of combinations of EHD proteins. 
As EHD4 was found to be expressed in the mTAL, its role in the regulation of the 
activity of NKCC2, an important cotransporter involved in setting up the osmotic gradient 
for urine concentration, was tested. The data, however, shows that EHD4 deletion does 
not affect the activity of NKCC2, as suggested by the comparable diuretic and natriuretic 
responses to furosemide in EHD4-KO and WT mice. Further, if EHD4 had a major role in 
NKCC2-trafficking, evidence of salt-wasting in EHD4-KO mice is to be expected. Although 
the metabolic cage data gives the appearance of a slight trend towards increased urinary 
sodium excretion in male EHD4-KO mice, 2 of the 9 WT mice had relatively lower sodium 
excretion than the rest of the group, which had similar levels of sodium excretion to the 
EHD4-KO mice. I did not observe any compensatory upregulation of ENaC alpha subunit 
expression in EHD4-KO mice, although changes in activity of ENaC or other distal sodium 
transporters masking the effects of the loss of EHD4 on NKCC2 cannot be ruled out. 
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Unfortunately, the approach to understand the role of EHD4 in regulating ENaC using 
amiloride was unsuccessful, possibly due to insufficient dosage and the results from this 
study remains inconclusive. Which and how many proteins in the kidney interact directly 
or indirectly with EHD4 is currently unknown. 
While these results clearly support a nephrogenic origin of diabetes insipidus seen 
in EHD4-KO mice, other possible explanations for their diuretic phenotype could include 
primary polydipsia (as discussed above), or defective AVP secretion from the 
hypothalamus, along with a faulty AVP-induced signaling cascade in the principal cells of 
the collecting duct. However, 24-hour urinary AVP excretion, which allowed me to 
indirectly assess circulating AVP (69), was comparable between WT and EHD4-KO mice, 
thereby suggesting that the defect in water reabsorption is not due to low circulating AVP. 
Direct measurement of circulating AVP would be ideal, however this is challenging to do 
in mice due to the potential confounding influences of stress, anesthesia and hypovolemia-
induced AVP secretion. Although urinary excretion of AVP represents an indirect index of 
circulating AVP, it has been shown by others that water-loading reduces urinary AVP 
excretion (53), supporting that this represents an indirect but physiologically-viable 
measurement. Both EHD4 and EHD1 are expressed in the hypothalamus, with an 
increase in EHD1 expression in the hypothalamus of EHD4-KO mice, suggesting that 
upregulation of EHD1 might compensate for the absence of EHD4. This suggests that in 
EHD4-KO animals, AVP synthesis or secretion may not be defective but that EHD4-KO 
mice develop a polyuric phenotype despite similar circulating AVP. This in turn could 
suggest a faulty renal response to AVP in EHD4-KO mice. I tried unsuccessfully to 
immunostain kidney sections for the V2 receptor due to technical difficulties with the 
commercial antibody, and so an effect on V2 receptor localization cannot be ruled out. 
EHD4-KO mice were also able to concentrate their urine in response to water restriction, 
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suggesting that the AVP-V2R-AQP2 axis possibly remains intact in EHD4-KO mice. 
Additionally, the apical membrane accumulation of AQP2 increased to a similar level in 
WT and EHD4-KO post-24-h water restriction. This indicates that the forward trafficking of 
AQP2 to the apical membrane during water restriction is functional in EHD4-KO mice, and 
further suggests that a major defect at the level V2 receptor is unlikely to underlie the 
phenotype observed in the EHD4-KO mice.  
The sum total of the data so far suggest that the apical accumulation of AQP2 in 
the EHD4-KO mice were significantly lower than in WT mice under baseline conditions. 
This indicates a possible role of EHD4 in the trafficking of AQP2 under baseline conditions. 
The current working hypothesis is, therefore, that EHD4 plays a role in regulating 
apical trafficking of AQP2 in the collecting duct under baseline conditions.  
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CHAPTER II: ROLE OF EHD4 IN THE REGULATION OF AQP2 
TRAFFICKING IN PRINCIPAL CELLS OF THE COLLECTING 
DUCT 4 
  
                                                
4 Parts of the material presented in this chapter was previously published: Rahman, S.S., Moffitt, 
A. E. J., Trease, A., Foster, F. W., Storck, M., Band, H., Boesen, E. I. EHD4 is a novel regulator of 
urinary water homeostasis. FASEB J. (2017) 
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Introduction 
The water permeability of the collecting duct is finely regulated by the presence or 
absence of AQP2 in the principal cells. Endocytic recycling plays an important role in the 
regulation of the presence of AQP2 in the apical membrane (18). Endocytic recycling of 
AQP2, as like other membrane proteins, starts with the entry of AQP2 into the early 
endosome (188). The transition of AQP2 from the early endosome to the other endosomal 
compartments depends on the state of the cell. In unstimulated cells, mere inhibition of 
endocytosis has been shown to result in an accumulation of AQP2 in the plasma 
membrane (112), indicating that the recycling process of AQP2 is very dynamic and can 
occur constitutively. In the presence of factors such as AVP and PGE2, the rate of insertion 
of AQP2-containing vesicles can be significantly regulated. AVP increases the 
phosphorylation of residues of AQP2 that favors its exocytosis (113, 123, 138, 144), 
whereas PGE2 may retard the exocytosis of AQP2 (148). In addition to these exogenous 
factors, the recycling of AQP2 depends on the presence of several different types of 
cellular proteins (18). AQP2-containing vesicles have been found to contain proteins that 
regulate endocytic recycling (5). One such protein, called Rab11-Fip2, has been shown to 
be important in the forward  trafficking of AQP2 (137). Rab11-Fip2 is known to interact 
with EHD proteins (136) and is important in the trafficking proteins from the recycling 
endosome to the plasma membrane (30). Although separate previous studies have 
established common interacting partners between AQP2 and EHD proteins, to our 
knowledge no studies have been performed to delineate the direct role of EHD proteins in 
the regulation of AQP2 trafficking. 
Experiments in the previous chapter demonstrated a reduced accumulation of 
AQP2 in the apical membrane of principal cells of EHD4-KO mice under baseline 
conditions, suggesting a role of EHD4 in the regulation of AQP2 trafficking. The membrane 
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abundance of AQP2 in EHD4-KO mice was increased during the water-restricted period, 
which indicates that EHD4 may only be required for the constitutive recycling of AQP2 in 
principal cells. Therefore, it is hypothesized that EHD4 regulates the trafficking of 
AQP2 in principal cells, and in the absence of EHD4, membrane accumulation of 
AQP2 in the principal cells will be reduced. A major aim of this chapter is, therefore, to 
study the effect of EHD4 deletion and depletion on AQP2 trafficking in in vivo and in vitro 
models of principal cells, and to understand the cellular and molecular mechanisms of 
how EHD4 may regulate AQP2. In the first series of experiments, the total cellular and 
membrane abundance of AQP2 is assessed in the presence and absence of EHD4. In 
order to identify the cellular mechanisms that might be involved in the regulation of AQP2 
by EHD4, a protein-protein interaction profile will be generated and the interaction 
between EHD4 and AQP2 will be tested by immunoprecipitation. Depletion of EHD4 has 
been previously shown to increase the activity of Rab5 proteins and enlarge the early 
endosome of HeLa cells (178). In a separate study, a similar increase in the activity of 
Rab5 proteins and early endosomal length were observed in murine macrophages when 
PGE2 was administered to the cells (203). PGE2 is a well-known negative regulator of 
AQP2 and reduces the accumulation of AQP2 in the apical membrane of principal cells. 
Because the cellular and physiological effects of EHD4 deletion is similar to that of 
increased PGE2 synthesis, an additional line of investigation will be performed to test to 
see if EHD4 regulates the synthesis of PGE2.  
Collecting ducts constitutively express AQP3 and AQP4 in the basolateral 
membrane of principal cells to provide an exit route for water, and previous studies have 
reported that mice lacking AQP3 or AQP4 can develop urine-concentrating defects (25, 
114). Therefore, this chapter will also assess the role of EHD4 in the regulation of AQP3 
and AQP4 in the principal cells of the collecting duct.  
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Methods 
Animals 
All animal studies were approved in advance by the Institutional Animal Care and 
Use Committee at the University of Nebraska Medical Center. Baseline metabolic cage 
experiments were conducted on 12 to 18-week old male and female EHD4-KO mice (n = 
6 for male; n = 5 for female) and age-matched male and female C57Bl/6 mice (WT) (n = 
9 for male; n = 4 for female (Jackson Laboratories, Bar Harbor, ME) as described in 
CHAPTER I (page no.31) to collect baseline urine.  
Cell culture  
The mouse cortical collecting duct principal cell line (mpkCCDc14 cells) was 
generously shared by Dr. Mark Knepper (NIH). These cells are known to express AQP2 
endogenously, and are widely accepted as a good in vitro model principal cell line to study 
AQP2 trafficking (67). The cells were grown in modified DMEM/F-12 medium with 
composition as described in (67) and were seeded on permeable filters (Transwell®, 0.4-
μm pore size, 1-cm2 growth area, Corning Costar, Cambridge, MA) at a density of 50,000 
cells/well for Western blotting and immunofluorescent analysis, and 100,000 cells/well for 
surface biotinylation unless otherwise stated.  
Cell transfection 
EHD4-siRNA transfection: Cells were grown to 70-80% confluency in a 6-well dish 
and subjected to Lipofectamine-2000-mediated transient transfection with 20 pmol/well 
solution of either a non-targeting (NT) siRNA (Catalogue# D-001210-01-05, 
Dharmacon™, Lafayette, CO) or an EHD4-specific siRNA (sequence: 3’ 
UGGAGGACGCCGACUUCG-AUU 5’) (Dharmacon™). Expression of EHD4 was 
measured in the transfected cells (by Western blot) after 48 hours to ensure knock down 
of EHD4.  
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EHD4-shRNA transfection: Cells were subjected to Lipofectamine 2000-mediated 
transfection followed by retroviral transduction with either a NT or an EHD4-specific 
shRNA (sequence: 3’ GAAGGCTCGAGAAGGTATATTGCTGTTGACAGTGAGCGATC-
GCCCATCAATGGCAAGATATAGTGAAGCCACAGATGTATATCTTGCCATTGATGGG
CGACTGCCTACTGCCTCGGACTTCAAGGGGCTAGAATTCGAGCA 5’) and positively 
selected for with 2 μg/mL puromycin (Sigma-Aldrich, St. Louis, MO). Transfected cells 
were grown on the filter for 3 days in complete media before switching to serum/hormone-
free media. To simulate baseline conditions, 0.1 nM d-deamino-arginine vasopressin 
(dDAVP) (Sigma-Aldrich, St. Louis, MO) was applied on the basolateral side for 24 h, while 
10 nM dDAVP was used as a stimulatory dose of dDAVP (67). At the end of the 24-h 
period, cells were extracted and lysed as described below. 
GFP-EHD4 plasmid transfection: Cells were grown on cover slips at a density of 
50,000 cells/well in a 24-well dish and allowed to grow to a 80-90% confluency. Next, the 
cells were subjected to Lipofectamine-2000-mediated transfection with GFP-tagged EHD4 
pCDNA3 plasmid, previously generated as described in (58). For transient transfection in 
each well, 7.5 μL Lipofectamine-2000 (Catalogue# 11668-027, ThermoFisher Scientific, 
Rockford, IL) and 3 μg plasmid DNA were separately diluted in 100 μL Opti-MEM™ 
(Catalogue# 31985070,  ThermoFisher Scientific) and allowed to incubate at room 
temperature for 20 minutes. During this incubation period, growth medium from each well 
was removed and 1 mL Opti-MEM™ was added to each well. After the incubation, diluted 
Lipofectamine-2000 was added to the diluted plasmid DNA and the mixture was incubated 
for another 20 minutes to allow complex formation. Finally, 250 μL of the final DNA-
Lipofectamine complex was slowly added to each well containing Opti-MEM™ and cells 
were incubated for 6 hours in the transfection media. After the final incubation, the 
transfection medium was removed and complete growth media was added to the cells. 
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Cells were allowed to grow for 48 hours post-transfection in the complete media before 
performing immunofluorescent staining. Cells treated with Lipofectamine-2000 but no 
GFP4-EHD4 plasmid were used as negative controls.  
Cell lysate preparation 
Confluent mpkCCDc14 cells were subjected to lysis by M-PER™ mammalian 
protein extraction reagent (78501, ThermoFisher Scientific, Rockford, IL) containing 1 mM 
phenylmethylsulfonyl fluoride, 2 µM Leupeptin, 1 µM Pepstatin A, 0.1% Aprotinin, and 10 
µL/mL Phosphatase inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Cells were incubated 
in the lysis buffer for 1 hour at 4 °C, followed by centrifugation of the lysates at 13,000 g 
for 10 minutes. Supernatant was collected and protein concentration of the lysate was 
measured as described in CHAPTER I (page no. 33). Lysates were stored at -80 °C until 
further analyses were performed. 
Surface biotinylation  
Control and EHD4 shRNA-transfected mpkCCDc14 cells were seeded at a density 
of 100,000 cells/well on semipermeable filters of Transwell systems and cultured for 3 
days prior to performing surface biotinylation as described in (152). Briefly, cells were 
treated with dDAVP (0.1 nM for baseline stimulation) for 24 h at 37°C at the basolateral 
sides. At the end of the 24-h period, cells were washed three times with ice-cold PBS-CM 
(10 mM PBS containing 1 mM CaCl2 and 0.1 mM MgCl2, pH 7.5), followed by incubating 
the cells for 45 min at 4°C in ice-cold biotinylation buffer (10 mM triethanolamine, 2 mM 
CaCl2, 125 mM NaCl, pH 8.9) containing 1 mg/ml sulfosuccinimidyl 2-(biotinamido)-ethyl-
1,3-dithiopropionate (Sulfo-NHS-SS-biotin, ThermoFisher Scientific, Rockford, IL) on the 
apical side. Cells were then washed once with quenching buffer (50 mM Tris-HCl in PBS-
CM, pH 8.0) and twice with PBS-CM, followed by lysing the cells as described above. The 
lysates were sonicated at 2 × 6 pulses at 20% of amplitude and centrifuged at 10,000 g 
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for 5 min at 4°C. Next, the supernatant was transferred to columns (Pierce Spin Column 
Snap Cap, Catalogue# 69725) (ThermoFisher Scientific, Rockford, IL), which were 
previously loaded with 200 μl Neutravidin agarose resin (ThermoFisher Scientific, 
Rockford, IL) and incubated for 60 min at room temperature with end-over-end mixing. At 
the end of the 60-minute incubation, the columns were centrifuged at 8000 rpm for 1 
minute and the flow through was discarded. After washing with degassed PBS containing 
protease inhibitors for 6-8 times, 50 μL of 1X sample buffer containing 50 mM DTT was 
added to the column and incubated for 60 min at room temperature. The final flow-through 
was collected in a 1.5 mL tube and heated at 65 °C for 10 minutes before proceeding to 
Western blotting. Lysates of cells that did not undergo biotinylation, but were otherwise 
prepared identically to biotinylated cells, including purification via Neutravidin agarose 
column, were used as a negative control. Total loaded protein was analyzed by RevertTM 
Total Protein Stain (LI-COR® Biosciences, Lincoln, NE). 
Co-immunoprecipitation of AQP2 and EHD4 
Confluent monolayer of mpkCCDc14 cells were grown on permeable filters at a 
density of 150,000 cells/well in a 6-well dish for 3 days. For the final 24 hours, either no or 
1 nM dDAVP (to stimulate AQP2 expression) was added to the basolateral side of the 
cells. Next, the cells were subjected to lysis as described above, followed by centrifugation 
at 13,000 g at 4 °C to collect the supernatant. AQP2 antibody was added to the 
supernatant at a 1:250 w/w ratio and incubated for 1 hour at 4 °C. Then, 20 μL of 
resuspended Protein A/G Plus-Agarose (sc-2003, Santa Cruz Biotechnology, Dallas, TX) 
kept at room temperature were added to the samples, and samples were incubated 
overnight at 4 °C on a rocker platform to ensure uniform mixing. Immunoprecipates were 
collected the following day by centrifugation of the samples at 1,000 g for 5 minutes and 
the supernatant was discarded. The pellets were washed with 1 mL 1X PBS for 5 times, 
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each time repeating the centrifugation step above. After the final wash, the supernatant 
was discarded and 40 μL of 1X electrophoresis sample buffer containing 10% glycerol, 50 
mM Tris-HCl (pH 6.8), 2% SDS, 0.005% bromophenol blue, and 2% 2-mercaptoethanol 
was added. Samples were heated for 15 minutes at 60 °C and subjected to SDS-PAGE 
to blot for EHD4. Cell lysates that were not incubated in AQP2 antibody but otherwise 
prepared identically to lysates with AQP2 antibody, including incubation with Protein A/G 
Plus-Agarose, were used as negative controls.   
Quantitative immunoblotting of aquaporins 
Expression levels of AQP2, AQP3, AQP4, phospho-serine256-AQP2 (pAQP2), 
and EHD4 in the renal tissues and cell lysates were analyzed by immunoblotting as 
described in CHAPTER I (page no. 34).  The following primary antibodies were used: goat 
anti-AQP2 (sc-9882, 1:2000 dilution); goat anti-AQP3 (sc-9885, 1:1000 dilution), and goat 
anti-AQP4 (sc-9888, 1:1000 dilution) (Santa Cruz Biotechnology, Dallas, TX); rabbit anti-
pAQP2 (ab-109926, 1:1000 dilution, AbCam, Cambridge, MA); rabbit anti-EHD4 (ab-
83859, 1:1000 dilution, AbCam, Cambridge, MA). 
Immunofluorescence staining of aquaporins 
Paraffin-embedded kidney sections from WT and EHD4-KO mice (n = 3-4 per 
group; 3-5 images per IM section) were subjected to immunofluorescent staining as 
described in CHAPTER I (page no. 35). Membrane abundance of AQP2, AQP3, AQP4 
and pAQP2 was quantified by measuring the pixel intensities of the channels within a 
consistent defined region of the apical (for AQP2 and pAQP2) or basolateral (for AQP3 
and AQP4) membrane using the image analysis tool ImageJ (freely downloaded from 
https://imagej.nih.gov/ij/). The analysis was performed in a blinded manner in 3-5 images 
of inner medulla in each mouse.  
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To analyze localization of AQP2 and GFP-tagged EHD4 in cultured principal cells, 
mpkCCDc14 cells were plated on cover slips as described above. Cells were fixed in 4% 
formaldehyde in 1X PBS for 20 minutes. Next, cells were washed in 1X PBS for 5 minutes 
and subjected to permeabilization by 0.075% Triton X-100 for 20 minutes. Cells were then 
blocked in 2 mg/ml BSA in 1X PBS for 30 minutes, followed by incubation in primary 
antibodies for 1 hour at 37°C. Fluorescently-tagged secondary antibodies (1:500 dilution) 
(Alexa Fluor® conjugates, ThermoFisher Scientific, Rockford, IL) were added next and 
cells were incubated for 1 hour at room temperature. Finally, cells were washed 3 times 
in 1X PBS, and mounting solution containing DAPI was added. The analysis was 
performed in 3-4 images for each treatment group (n = 3 per treatment group, with n being 
the number of separate experiments). 
The following primary antibodies were used: goat anti-AQP2 (1:2000 dilution), goat 
anti-AQP3 (1:100 dilution), goat anti-AQP4 (1:100 dilution), rabbit anti-pAQP2 (1:1000 
dilution), rabbit anti-GFP (ab-6556, 1:200 dilution, AbCam, Cambridge, MA). 
Measurement of PGE2 
Cells were plated in a 6-well dish at a density of 100,000 cells/well. After 24 hours, 
the complete growth media were removed and a serum/hormone-free media was added 
to the cells. Next, the cells were subjected to siRNA transfection as described above and 
were allowed to grow for 48 hours. At the end of the 48-h period, 1 mL media surrounding 
the cells was collected and the amount of PGE2 released was measured. PGE2 level in 
urine and cell culture media was measured according to the manufacturer’s instructions 
with a PGE2 ELISA kit (Catalogue# 514010, Cayman Chemicals, Ann Arbor, MI).  
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Protein-protein interaction map 
The protein-protein interaction map for EHD4 was generated using the 
bioinformatics tool STRING ver. 10.5 (available at www.string-db.org). STRING 10.5 is a 
database of known and predicted protein interactions. The interactions were derived from 
four sources: genomic context, high-throughput experiments, coexpression, and existing 
knowledge from literature database. The minimum required interactions score was set at 
medium confidence of 0.400, with the highest score being 0.900. 
Statistical analyses 
Statistical analyses were performed using GraphPad Prism 6 for Windows 
(GraphPad Software Inc., La Jolla, CA) as described in CHAPTER I.  
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Results 
EHD4 deletion reduces accumulation of AQP2 in the apical membrane and AQP4 in the 
basolateral membrane of principal cells 
As urine osmolality of euhydrated mice was reduced and urine flow increased in 
EHD4-KO mice compared to WT mice, total cellular abundance of AQP2, AQP3, and 
AQP4, as well as pAQP2 in the renal inner medulla of these two genotypes were 
compared. As shown in Figures 16A and 17A, there was no difference in the total AQP2 
and pAQP2 protein level in the inner medullas of the two groups. However, 
immunofluorescence staining of AQP2 as well as pAQP2 was more dispersed within 
principal cells of EHD4-KO mice compared to WT mice, which showed a clear apical 
localization of AQP2 in principal cells of the collecting duct (Fig. 16B and 17B). Moreover, 
apical pixel intensity of both AQP2 and pAQP2 was significantly reduced (~20% for AQP2 
and ~40% for pAQP2) in EHD4-KO mice compared with WT, indicating reduced 
membrane accumulation of AQP2 and pAQP2 in EHD4-KO mice. Additionally, a robust 
decline in the basolateral membrane intensity of AQP4 staining in EHD4-KO mice (~70% 
reduction) was found when compared to the WT mice, although total staining of AQP4 
also appeared to be significantly reduced in EHD4-KO mice (Fig. 18A). Using the same 
AQP4 antibody, Western blot analysis showed a slight reduction in glycosylated-AQP4 
and a significant increase in non-glycosylated-AQP4 (Fig. 18B). Basolateral abundance 
of AQP3 (Fig. 19) was comparable in both the genotypes. 
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Figure 16: EHD4 regulates localization of AQP2 in the IM of mice 
kidney. (A) Representative immunoblot and densitometric 
quantification of AQP2 in the IM of female WT and EHD4-KO mice. (B) 
Representative immunofluorescent image and blinded quantification of 
apical intensity of renal IM of male WT and EHD4-KO mice with AQP2 
antibody. Original magnification, X60. Graphed data are means ± SEM 
of n mice (in parentheses). P values were determined by unpaired t test. 
Figure 16: EHD4 regulates localization of AQP2 in the IM of mice kidney 
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Figure 17: EHD4 regulates localization of pAQP2 in the IM of 
mice kidney. (A) Representative immunoblot and densitometric 
quantification of pAQP2 in the IM of female WT and EHD4-KO mice. 
(B) Representative immunofluorescent image and blinded 
quantification of apical intensity of renal IM of male WT and EHD4-
KO mice with pAQP2 antibody. Original magnification, X60. 
Graphed data are means ± SEM of n mice (in parentheses). P 
values were determined by unpaired t test. 
Figure 17: EHD4 regulates localization of pAQP2 in the IM of mice kidney 
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Figure 18: EHD4 regulates expression of AQP4 in the basolateral 
membrane of the collecting duct. (A) Representative immunofluorescent 
images and blinded quantification of AQP4 in the IM of male WT and EHD4-
KO mice. Scale bars, 10 μm. (B) Representative immunoblot and 
densitometric quantification of glycosylated and non-glycosylated AQP4 in 
the IM of male WT and EHD4-KO mice. Graphed data are means ± SEM of 
n mice (in parentheses). P values were determined by unpaired t test. 
Figure 18: EHD4 regulates expression of AQP4 in the basolateral membrane of the collecting duct 
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Figure 19: Effect of EHD4 deletion on the basolateral 
expression of AQP3. Representative immunofluorescent 
images and blinded quantification of AQP3 in the IM of male 
WT and EHD4-KO mice. Scale bars, 10 μm. Graphed data 
are means ± SEM of n mice (in parentheses). P values were 
determined by unpaired t test. 
Figure 19: Effect of EHD4 deletion on the basolateral expression of AQP3 
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EHD4 deletion decreases the accumulation of glycosylated AQP2 in the apical membrane 
of cultured principal cells 
Although the blinded quantification of the apical membrane pixel intensity of AQP2 
immunofluorescence staining presented in Figure 16 suggests that EHD4-KO mice have 
reduced apical membrane AQP2 abundance, it remains possible that some of the 
difference in intensity detected may reflect a difference in the sub-apical space as well as 
or rather than the apical membrane itself. To further confirm the role of EHD4 in the 
regulation of apical membrane AQP2 localization in principal cells under baseline 
conditions, mpkCCDc14 cell line was stably transfected with either NT or EHD4-specific 
shRNA. Transfection with EHD4-shRNA resulted in an almost 65% reduction in the 
expression of EHD4 protein as compared to that in control cells (Fig. 20). These 
mpkCCDc14 cells are known to express AQP2 endogenously and the expression of AQP2 
is upregulated in a dose-dependent manner in the presence of dDAVP (67), which was 
also demonstrated in cultured cells used in this study (Fig. 21). As shown in Figure 18, 
knock down of EHD4 in mpkCCDc14 cells did not significantly affect the total abundance of 
AQP2 at baseline (0.1 nM dDAVP) or after a 10 nM stimulatory dose of dDAVP (Pgenotype 
> 0.05), and dDAVP increased the expression of glycosylated and non-glycosylated AQP2 
in both control and EHD4-shRNA cells in a similar manner (PdDAVP = 0.013, Pinteraction > 
0.05), indicating an EHD4-independent effect of dDAVP on the total expression of AQP2. 
Surface biotinylation of apical AQP2 revealed that knock down of EHD4 in mpkCCDc14 
cells significantly reduced the apical level of glycosylated but not non-glycosylated AQP2 
compared to that observed in NT-shRNA (control) cells (Fig. 22), corroborating the 
reduction in apical immunofluorescence staining observed in EHD4-KO mouse kidney 
sections in Figure 16.  
  
82 
 
  
β-actin 
EHD4 
Control 
shRNA
EHD4  
shRNA
Figure 20: EHD4 expression in shRNA-transfected 
mpkCCDc14 cells. Representative immunoblot and 
densitometric quantification of EHD4 in mpkCCDc14 
cells transfected with either non-targeting (control) or 
EHD4-specific shRNA. Graphed data are means ± 
SEM of n separate experiments (in parentheses). P 
values were determined by unpaired t test. 
Figure 20: EHD4 expression in shRNA-transfected mpkCCD cells 
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Figure 21: Effect of EHD4 knockdown on the expression of total AQP2 in 
mpkCCDc14 cells. Representative immunoblot and densitometric quantification 
of glycosylated and non-glycosylated AQP2 in control and EHD4-shRNA cells 
treated with 0.1 nM dDAVP (baseline stimulation) for 24 h, followed by a 
stimulatory dose of 10 nM dDAVP. Graphed data are means ± SEM of n 
separate experiments (in parentheses). P values were determined by 2-factor 
ANOVA to test for the effects of genotypes (Pgenotype), dDAVP (PdDAVP), and the 
interaction between dDAVP and genotype (Pinteraction).  
Figure 21: Effect of EHD4 knockdown on the expression of total AQP2 in mpkCCD cells 
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Figure 22: Effect of EHD4 knockdown on the cell surface expression of AQP2 in mpkCCD cells 
Figure 22: Effect of EHD4 knockdown on the cell surface expression of AQP2 in 
mpkCCDc14 cells. Representative immunoblot and densitometric quantification of AQP2 
after surface biotinylation of mpkCCDc14 cells. Lysates of cells that did not undergo 
biotinylation, but were otherwise prepared identically to biotinylated cells, including 
purification via the Neutravidin agarose column, were used as a negative control. Total AQP2 
surface and cytosolic fractions that were not passed through column) in whole-cell lysate 
(WCL; C = control, E = EHD4-shRNA) and biotinylated-AQP2 fractions (BF; C = control, E = 
EHD4-shRNA) were loaded and the appropriate bands for glycosylated and non-glycosylated 
AQP2 were confirmed by running a WT IM homogenate. A high saturation image of the same 
blot is shown below to show the bands in the BF samples more clearly. Total loaded protein 
was used for normalizing the quantification of AQP2 intensity. For representative images of 
Western blots, white gaps indicate where intervening lanes were spliced out, with vertical 
alignment maintained as per the original blot. Graphed data are eans ± SEM of n separate 
experiments (in parentheses). P values were determined by unpaired t test.  
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Protein-protein interaction profile of EHD4 shows possible interaction of EHD4 with 
regulators of water reabsorption and AQP2 trafficking 
To understand the role of EHD4 in the regulation AQP2 trafficking in principal cells, 
an interaction profile of EHD4 using STRING ver. 10.5 (Fig. 23) was generated. Three of 
the EHD4-interacting proteins, namely Rab5a, Rab5b, and Rab5c, were discovered as 
proteins involved in the regulation of water reabsorption (KEGG pathway ID: 04962, false 
discovery rate = 0.000347). Interactions between EHD4 and Rab5 proteins were all 
derived from text-mining. Additionally, EHD4 was also shown to interact with Rab11-Fip2 
(interaction score = 0.892), an important regulator of AQP2 shuttling (137).  
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Figure 23: Protein-protein interaction profile of EHD4. STRING ver. 10.5 was used to 
generate the predicted interaction profile of EHD4 in mouse. The minimum confidence score 
was set at 0.400, with the highest score being 0.900. 
Figure 23: Protein-protein interaction profile of EHD4 
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EHD4 co-localizes, but may not physically interact, with AQP2 in cultured principal cells  
To better understand the interaction between EHD4 and AQP2, the cellular 
localization of EHD4 and AQP2 was examined in mpkCCDc14 cells transfected with GFP-
tagged EHD4 pCDNA3. Transfected cells containing GFP-EHD4 show the characteristic 
localization of EHD4 in pleomorphic tubulovesicular structures in the perinuclear region 
and around the cell periphery (58) (Fig. 24). When co-stained with AQP2 antibody, GFP-
EHD4 was found to localize with AQP2 in the transfected mpkCCDc14 cells (Fig. 25), 
indicating that EHD4 exists in close proximity to AQP2. To test if EHD4 physically interacts 
with AQP2, immunoprecipitation of AQP2 from mpkCCDc14 cells (Fig. 26) was performed. 
As shown in Figure 26, EHD4 was not found in the immunoprecipitates containing AQP2, 
suggesting a lack of direct physical contact between AQP2 and EHD4.  
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Figure 24: Transfection of mpkCCDc14 cells with GFP-tagged 
EHD4 pCDNA3. Representative immunofluorescent image of 
cultured mpkCCDc14 cells transfected with or without GFP-tagged 
EHD4 pCDNA3. Original magnification, X60.
Figure 24: Transfection of mpkCCD cells with GFP-tagged EHD4 pCDNA3 
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Figure 25: EHD4 co-localizes with AQP2 in mpkCCDc14 cells. 
Representative immunofluorescent image of cultured mpkCCDc14 cells 
transfected with or without GFP-tagged EHD4 pCDNA3 and co-stained with 
AQP2. Original magnification, X60.
Figure 25: EHD4 co-localizes with AQP2 in mpkCCD cells 
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EHD4 deletion increases the urinary PGE2 excretion in mice 
To test the hypothesis that EHD4 regulates PGE2 synthesis, the urinary PGE2 
excretion in WT and EHD4-KO mice was measured. Urinary PGE2 excretion of EHD4-KO 
mice was significantly higher than that in WT mice (Fig.  27), indicating a potential role of 
EHD4 in the regulation of PGE2 synthesis. 
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Fig 27: Effect of EHD4 deletion on the urinary PGE2 
excretion in female mice. WT and EHD4-KO female mice 
were placed in metabolic cages for 24 hours and urine was 
collected to measure urinary PGE2 excretion. Data shown are 
mean ± SEM for n mice (in parentheses). Data were 
compared using unpaired t-test.  
Figure 27: Effect of EHD4 deletion on the urinary PGE2 excretion
in female mice 
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EHD4 regulates the synthesis of PGE2 in cultured principal cells 
To test the role of EHD4 in the regulation of PGE2 synthesis in principal cells, 
EHD4 expression was transiently knocked down in mpkCCDc14 cells with EHD4-siRNA 
and measured the amount of PGE2 released into the media as an indicator of PGE2 
synthesis. EHD4-siRNA transfection caused a robust (~92%) reduction in the expression 
of EHD4 expression in mpkCCDc14 cells within 48 hours (Fig. 28). Moreover, EHD4-siRNA 
treated cells released significantly more PGE2 into the surrounding media than control 
NT-siRNA cells (Fig. 29), indicating an increased synthesis of PGE2 in EHD4-depleted 
cells. 
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Figure 28: EHD4 expression in siRNA-transfected 
mpkCCDc14 cells. Representative immunoblot and 
densitometric quantification of EHD4 in mpkCCDc14 
cells transfected with either non-targeting (NT) or 
EHD4-specific siRNA for 48 h. Graphed data are 
means ± SEM of n separate experiments (in 
parentheses). P values were determined by unpaired 
t test.  
Figure 28: EHD4 expression in siRNA-transfected mpkCCD cells 
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Figure 29: EHD4 regulates the synthesis of PGE2 in 
mpkCCDc14 cells. Data are presented for the concentration of 
PGE2 level in the media surrounding siRNA transfected 
mpkCCDc14 cells collected after 48 h of transfection.  Graphed 
data are means ± SEM of n separate experiments (in 
parentheses). P values were determined by unpaired t test.  
Figure 29: EHD4 regulates the synthesis of PGE2 in mpkCCD cells 
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Discussion 
This section focused on the role of EHD4 in the regulation of AQP2 trafficking in 
principal cells of the collecting duct. These data show that when EHD4 is deleted the 
membrane abundances of AQP2 and AQP4 is significantly reduced. It was also found that 
EHD4 co-localizes with AQP2 in principal cells, but may not physically interact with AQP2. 
Moreover, EHD4 has been found to regulate the synthesis of PGE2 both in vivo and in 
vitro, providing an additional mode of regulation of the trafficking of AQP2 in principal cells.  
In the absence of EHD4, the subcellular distribution of both AQP2 and pAQP2 was 
found to be altered in the principal cells of the kidney. In collecting duct principal cells of 
WT mice, AQP2 and pAQP2 were more apically localized, whereas in EHD4-KO mice, 
these proteins were dispersed throughout the principal cells. Moreover, the apical 
accumulation of both AQP2 and pAQP2 was significantly reduced in the absence of EHD4, 
as evident from the reduced immunofluorescence staining intensity quantified at the apical 
membrane of EHD4-KO mice. The regions of interest for this blinded analysis of the 
confocal immunofluorescence images were drawn close to and including the apical 
membrane. It therefore remains possible that some of the AQP2 staining intensity included 
in the analyzed regions was attributable to a difference in sub-apical as well as apical 
AQP2. However, surface biotinylation of mpkCCDc14 cells following silencing of EHD4 also 
demonstrated a significant reduction of glycosylated AQP2, suggesting that the reduced 
immunofluorescence intensity detected reflected a reduced apical localization of AQP2. 
Together, these findings indicate that less AQP2 is available in the apical membrane to 
facilitate water reabsorption in EHD4-KO mice, which may contribute to the polyuria in 
these mice.   
Under baseline conditions, AQP2 is constitutively trafficked between the apical 
membrane, subapical vesicles and basolateral membranes (75), and when AVP levels are 
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low, AQP2 is mainly localized to the sub-apical endocytic vesicles (138). Binding of AVP 
to its V2 receptor in the principal cells induces the phosphorylation of AQP2 at ser-256 
residue (138) and allows its translocation to the apical membrane (139). At the level of 
molecular interactions, this seemingly simple trafficking process requires the coordinated 
activities of multiple molecules. AVP binding to its receptor triggers several downstream 
signaling pathways: cAMP-mediated PKA activation, elevated intracellular Ca2+ level, and 
activation of other protein kinases (146). Phosphorylation of AQP2 is followed by 
reorganization of the actin cytoskeleton (187, 190) and allows traffic of AQP2 to the apical 
membrane. Accordingly, AQP2 trafficking within the cell involves the intricate interactions 
of many proteins (18). To our knowledge, no studies to date have determined whether 
AQP2 might directly bind with EHD4, therefore, it was examined if EHD4 physically 
interacts with AQP2 in principal cells. The immunoprecipitation data do not support direct 
physical interaction between AQP2 and EHD4; however the complex nature of AQP2 
trafficking allows the possibility of EHD4 being a part of AQP2 traffic regulation through an 
indirect interaction with components of the endocytic traffic machinery. For example, actin 
cytoskeleton dynamics has been suggested to be regulated by EHD proteins via their 
interaction with Syndapin (PACSIN) I and II (13, 60) and therefore provides potential for 
the involvement of EHD proteins in AQP2 trafficking. Moreover, absence of Rab11-Fip2, 
one of the interacting partners of EHD proteins (136), disrupts the recycling of AQP2 (137), 
providing another possible link to the involvement of EHD proteins in AQP2 trafficking. 
Additionally, EHD4 was found to co-localize with AQP2 in principal cells, strongly 
indicating a close proximity of the two proteins and a possible indirect interaction between 
the two proteins. The lack of EHD4 may eventually reduce the association of AQP2 with 
important trafficking proteins, and thereby stall the constitutive recycling of AQP2. Further 
biochemical analyses to define the mechanism and molecular interactions by which EHD4 
regulates AQP2 represent an exciting future direction. 
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AVP is a potent stimulator of the forward trafficking of AQP2. In the presence of 
AVP, AQP2-containing vesicles shift from the sub-apical region and fuse with the apical 
membrane, thereby increasing the amount of AQP2 in the apical membrane of principal 
cells (18). It could be possible that EHD4 deletion stalls the forward trafficking of AQP2 in 
the principal cells that ultimately reduces the membrane availability of AQP2. However, 
the data showed a similar increment in the amount of AQP2 in the apical membrane of 
both WT and EHD4-KO mice after water restriction. This data suggest that the forward 
trafficking of AQP2 may occur independently of EHD4. It is currently not known which part 
of the AQP2 recycling process is regulated by EHD4. Trafficking of membrane proteins 
like AQP2 through the endosomal system is a very dynamic process and in order to study 
the transition of AQP2 through each of the endosomal compartment in the absence of 
EHD4 would require a more sophisticated tool such as live-cell imaging technique coupled 
to pulse-chase experiments rather than a routine immunofluorescence analysis. Co-
staining AQP2 with specific endosomal compartment marker would only provide a snap 
shot of the total process, and therefore, would not be an ideal technique for assessing the 
role of EHD4 in the constitutive recycling of AQP2. Because there is an overall reduction, 
and not absolute absence, of AQP2 in the apical membrane in the absence of EHD4, it is 
very likely that the speed of AQP2 recycling becomes very slow EHD4-depleted principal 
cells, and such a hypothesis can only be tested using live-cell imaging, which was beyond 
the feasible and technical scope of this study.  
PGE2 is the primary product of arachidonic acid metabolism pathway and is a 
known negative regulator of AQP2 trafficking (148). Several studies has defined the role 
of PGE2-mediated AQP2 regulation as an additional mode of increasing water 
permeability of the collecting duct (149, 183). The data has so far suggested that the role 
of EHD4 in the regulation of AQP2 trafficking is AVP-independent. Moreover, EHD4 was 
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observed to co-localize with AQP2 in principal cells, but EHD4 and AQP2 could not be 
precipitated together. Although it is possible that EHD4 may interact with AQP2 indirectly, 
an alternative mechanism of regulation of AQP2 by EHD4 cannot be ruled out. Therefore, 
additional pathways that may be involved in the regulation of AQP2 in the absence of 
EHD4 were examined. PGE2 regulates AQP2 as well as other proteins that are also 
regulated by EHD4 (203). These observations provided us with grounds for analyzing the 
effect of EHD4 on the production of PGE2. Both the in vivo and in vitro data have shown 
that EHD4 regulates the synthesis of PGE2. In mice, the deletion of EHD4 resulted in an 
increase in the urinary PGE2 excretion, which was further confirmed in our cultured 
principal cells where knock down of EHD4 resulted in increased synthesis of PGE2. These 
data suggest that in the absence of EHD4 there is an increased production of PGE2, which 
may then inhibit the recycling of AQP2 in principal cells. Production of PGE2 in a cell 
depends on the translocation of cytosolic phospholipase A2 (cPLA2) enzyme to the 
membrane in order to initiate the metabolism of arachidonic acid (39). It could be possible 
that EHD4 regulates the translocation of cPLA2 and thereby regulates the synthesis of 
PGE2. The exact mechanism of how EHD4 regulates PGE2 synthesis awaits further 
investigation.  
AQP4 makes an important contribution to the water permeability of the inner 
medullary collecting duct (25). As visualized by confocal immunofluorescence staining, 
there was a robust attenuation of the basolateral accumulation of AQP4, but not AQP3, in 
EHD4-KO mice, indicating that exit of water from the principal cells may also be impaired 
in these mice. However, a divergent expression profile of AQP4 was observed in EHD4-
KO mice via immunoblotting. Although the total abundance of inner medullary AQP4 was 
similar between WT and EHD4-KO mice (bands quantified together), there was a 
significant increase in the non-glycosylated AQP4 (lower band) and a slight decrease in 
100 
 
glycosylated AQP4 (upper band) in EHD4-KO mice. One possible technical explanation 
for the discordant Western blot and immunofluorescent staining data could be that the 
antibody used for AQP4 has a preferential selectivity for glycosylated-AQP4 epitope in 
immuno-stained kidney sections, reducing the apparent overall abundance. Current 
understanding of AQP4 trafficking to the basolateral membrane is limited, in part due to 
technical challenges associated with studying the basolateral membrane of the collecting 
duct, and the exact role of EHD4 in this mechanism awaits further investigation. Previous 
studies have shown that sorting of AQP3 and AQP4 in trans-Golgi network for the 
basolateral membrane occurs separately (3), which could explain why only AQP4 
membrane accumulation, and not AQP3, was reduced in EHD4-KO mice. In addition, the 
lack of a change in localization of AQP3 in EHD4-KO mice demonstrates that there is 
specificity in terms of which proteins EHD4 regulates. Current understanding of AQP4 
trafficking to the basolateral membrane is limited and the exact role of EHD4 in this 
mechanism needs further investigation. 
Similar to the data on AQP4, I also observed a significant reduction in the 
membrane abundance of glycosylated APQ2 only. Glycosylation is an important post-
translational process for proper targeting of membrane proteins (197), including AQP2 
(68). Around 25% of the newly-synthesized AQP2 undergoes glycosylation and this post-
translational process is required for the exit of AQP2 from the Golgi and eventual sorting 
at the plasma membrane (68). My data on the reduced level of only the glycosylated AQP2 
and AQP4 suggest a possible role of EHD4 in the regulation of exit of newly-synthesized 
AQPs from the Golgi in the principal cells. However, very little is known about the exact 
role of glycosylation on AQP trafficking, which makes interpreting these data difficult. Data 
so far suggest that the AVP-stimulated forward trafficking of the AQP2 does not require 
EHD4. It is possible that trafficking of subapical AQP2-containing vesicles that have 
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already exited Golgi do not require EHD4 to be inserted into the plasma membrane. 
Although there no increase in the total amount of other EHD paralogs in the EHD4-KO 
mice, it is possible that there is functional compensation by another EHD paralog allows 
the exit of some of the AQP2-containing vesicles from the Golgi in the absence of EHD4.  
Altogether, data from this chapter show that EHD4 regulates the cellular 
distribution of AQP2 and AQP4 in the principal cells. The reduced accumulation of AQP2 
and AQP4 in their respective membrane in EHD4-KO mice may be responsible for the 
diuretic phenotype in these animals. Additionally, deletion of EHD4 increases the 
synthesis of PGE2 in the principal cells, which might be responsible for the reduced 
membrane accumulation of AQP2 in principal cells. Although the aquaporins were mainly 
investigated in this chapter to understand the role of EHD4 in renal water handling, several 
other renal processes may be affected by the deletion of EHD4 and contribute to the 
observed phenotype. Urea uptake and recycling within the inner medulla, and the renal 
medullary osmotic gradient are additional important factors in underlying renal water 
reabsorption and urinary concentrating ability. Analysis of the role of EHD4 in renal urea 
handling and whether EHD4 might regulate urea transporters is, therefore, the focus of 
the next section.  
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CHAPTER III: ROLE OF EHD4 IN THE REGULATION OF 
RENAL UREA HANDLING 
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Introduction 
Maintenance of constant plasma osmolality is vital to sustaining normal 
physiological functions and is tightly regulated by the kidney. Kidneys have the ability to 
regulate water excretion independently of sodium excretion, thereby allowing conservation 
of this major cationic osmotic constituent of the plasma. When required, kidneys are able 
to concentrate the urine from an osmolality of ~290 to ~1200 mOsm/kg H2O simply by 
increasing the amount of water reabsorbed in the collecting ducts (174). In this way, 
kidneys are able to produce a "hyperosmotic" urine — urine with an osmolality greater 
than that of the plasma. The architecture of the nephron segments within the kidney (151, 
174) allows establishment of a progressively increasing osmotic gradient starting from the 
cortico-medullary boundary to the tip of the papillary inner medulla. This osmotic gradient 
of the renal interstitium drives the sodium-independent water reabsorption in the kidney. 
Establishment and maintenance of this osmotic gradient also depends on the tight cellular 
regulation of the abundance of water and solute transporters as well as other proteins in 
the tubular epithelium and renal vasculature. These regulatory steps, in addition to other 
factors such as central osmoreceptors and voluntary water intake, act in concert to keep 
the plasma osmolality constant. 
Urea, generated in the liver by the breakdown of protein, is one of the two major 
osmotic constituents of the inner medullary osmotic gradient, and is the predominant 
solute in the urine during strong anti-diuresis (174). High interstitial urea concentration 
within the inner medulla is established by renal urea recycling that occurs via the various 
renal urea transporters. Urea reabsorption in the kidney is passive, and the permeability 
of the tubule to urea varies across the nephron section (117). As the filtrate moves along 
the nephron, urea concentration in the tubular lumen keeps increasing due to 
disproportional reabsorption of water, and the urea concentration reaches the highest in 
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the medullary collecting duct, where this high concentration of tubular urea drives the 
passive reabsorption of urea via the urea transporters, thereby setting the steep interstitial 
osmotic gradient (117).  
Urea transporters comprise 2 large subfamilies, UT-A and UT-B (88), and each 
member of these subfamilies are differentially expressed in mammalian tissues. Of the 
UT-A subfamily, UT-A1, A2, A3, and A4 are all expressed in the kidney tubular epithelium, 
whereas UT-B is expressed in the renal vasculature, specifically the descending vasa 
recta (88). UT-A1 is present on the apical plasma membrane of the principal cells of the 
collecting ducts; UT-A2 is expressed within the descending thin limb of the loop of Henle; 
UT-A3 is localized on the basolateral membrane of the principal cells of the collecting 
ducts; and UT-A4 is present in the rat kidney medulla (88). Owing to their exclusive 
localizations in the collecting ducts, UT-A1 and -A3 serve as vital points of regulation of 
renal medullary urea recycling. Indeed, mice that lack both UT-A1 and -A3 develop severe 
defects in their urine-concentrating abilities (44) due to the failure to establish a functional 
interstitial osmotic gradient, resulting in severe urea-induced osmotic diuresis. When 
maintained on a 20% diet, the urine volume of UT-A1/A3 double knockout mice is almost 
twice and the urine osmolality is almost half of that of wild type mice (45). Moreover, this 
basal urine-concentrating defect in UT-A1/A3-null mice is restored when UT-A1 is 
overexpressed in the mice (92), indicating that UT-A1 is absolutely required for maximal 
urine-concentrating ability. The membrane abundance and cellular localization of UT-A1 
are regulated by endocytosis (186), an EHD4-regulated cellular mechanism (178). 
Additionally, the diuretic phenotype of UT-A1/A3 mice is very comparable to that of EHD4-
KO mice. Also, it has been reported that EHD1 interacts with snapin (204), a common-
interacting partner of UT-A1 (122). Although the study focused only on EHD1, and EHD4 
has not studied as extensively as EHD1, it is possible that EHD4 may also interact with 
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snapin and thereby regulate UT-A1 via snapin.  Therefore, it is possible that the diuresis 
in EHD4-KO mice may arise due an increased urea load in the renal tubules resulting from 
a reduced membrane abundance of UT-A1. Hence, it is hypothesized that EHD4 
regulates the membrane accumulations of UT-A1 of the IMCD, thereby affecting 
renal urea handling, and regulating the generation of the osmotic gradient in the 
kidney. 
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Methods 
Animals 
All animal studies were pre-approved by the Institutional Animal Care and Use 
Committee at the University of Nebraska Medical Center. Male (n = 6-7) and female (n = 
5) Ehd4-/- (EHD4-KO) mice were bred from heterozygous Ehd4+/- parents, which were 
previously generated on a C57Bl/6 background as described in (56). Age-matched wild-
type (WT) C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) (male, n = 8-9; female, 
n = 4) or littermate Ehd4+/+ (EHD4-HOM) mice (male, n = 7; female, n = 4) were used as 
control groups. In all experiments, animals were 14-18 weeks old and were housed in 
cages maintained at room temperature, 60% humidity with a 12/12 hour light/dark cycle. 
Unless otherwise stated, mice were given free access to regular rodent chow (7012, 
Harlan Teklad, Madison, WI) and drinking water. 
Analysis of urine in mice fed with standard rodent chow 
Age-matched WT and EHD4-KO mice were placed in individual metabolic cages 
for 24 hours to collect urine for analyzing the baseline urinary urea excretion. Animals had 
free access to standard rodent chow containing 19% protein (7012, Harlan Teklad, 
Madison, WI) and drinking water, and were returned to their home cage at the end of the 
experiment for a week. At the end of the week, the animals were sacrificed to collect renal 
tissues for immunoblotting and histological analyses. 
Modified protein diet protocol 
To better understand the physiological role of EHD4 in the regulation of renal urea 
handling, systemic urea load was manipulated by modifying the protein content in the 
rodent chow. The rationale for this approach was based on the Berliner hypothesis (8), 
which states that in the absence of functional urea transporters in the kidney epithelium a 
high protein diet will result in a diuretic phenotype. Subsequently, this diuretic phenotype 
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can be rescued by restricting protein intake via feeding of a low protein diet. Accordingly, 
I proceeded with this approach by cycling the feeding routine in mice every 10 days from 
normal (20%) to high protein (40%) diet, then switching the high protein diet to a low 
protein (6%) one. To determine the effect of dietary protein intake on renal urea handling, 
EHD4-HOM and EHD4-KO mice were fed with specialized protein diets were purchased 
from Harlan Teklad (Madison, WI). These diets are isocaloric (3.8 Kcal/g) and are matched 
in calcium (0.7%) and phosphorus content (0.54%). The predominant protein source is 
casein and the calories are matched by adjusting the amount of carbohydrates. Protein 
diets were divided into the following three categories: low (6% protein; Harlan Teklad cat# 
TD. 160634), normal (20% protein; Harlan Teklad cat# TD. 160635), and high (40% 
protein; Harlan Teklad cat# TD. 160636). Mice were cycled through 20% (closest to the 
animal facility standard rodent chow), then 40%, and then 6%. Mice ate the modified 
protein diet for 7 days in their home cage and were then placed in individual metabolic 
cages for 48 hours with access to drinking water and the corresponding protein diet. Mice 
were allowed to acclimate to the metabolic cage environment for the first 24-h period, and 
urine was collected over the final 24-h period for baseline urinary analysis. At the end of 
the entire protein diet protocol, all animals were switched to 20% protein diet for at least 7 
days before sacrificing the mice to collect renal tissues for osmolality measurements.  
Measurement of tissue osmolality 
Renal tissue osmolality was measured using a method described previously in 
(147, 177). Briefly, kidneys were rapidly excised, de-capsulated, and dissected to collect 
the total inner medulla and similar-sized cortex and outer medulla. Excised tissue samples 
were next put in pre-weighed 200 µL tubes and the wet weight of the tissues were 
measured immediately. Next, the tissues were held at 60 °C in a dry oven. The oven was 
dried using Drierite (W. A. Hammond Drierite CO. LTD., Xenia, OH) for 48 hours before 
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the start of tissue collection. The tissues were allowed to dry out for 8 hours before 
measuring the final dry weight of the tissue samples. Following the dry weight 
measurement, tissue samples were immersed in 25 µL distilled water and solutes were 
allowed to diffuse out of the tissues into the water for 24 hours at 4 °C. After the 24-h 
incubation, tubes were briefly centrifuged and the supernatant were collected for 
biochemical analyses. Apparent urea concentration in tissue water (CT) was calculated as 
follows using the concentration in the supernatant (CS) and the dilution introduced by 
adding 25 μL of water to the dry material: 
CT = CS * [25 / (wet weight – dry weight in mg)] 
Biochemical assays 
Plasma, urine, and tissue urea concentration was measured according to the 
manufacturer's instructions using the QuantiChrom™ Urea Assay Kit (BioAssay Systems, 
Hayward, CA). Osmolality of the supernatant collected for tissue osmolality measurement 
was measured using a vapor pressure osmometer (model 5520, Wescor, Logan, UT).  
Quantitative immunoblotting 
Renal tissues were homogenized and prepared for Western blotting as described 
in CHAPTER I (page no. 34). An antibody directed against the C-terminal of UT-A1, 
previously validated for use in immunoblotting (143), was generously shared by Dr. Janet 
Klein, Emory University.  
Immunofluorescence staining 
Immunofluorescent analysis of at least 3 images of the inner medulla of WT and 
EHD4-KO mice (n = 4 mice per group) were performed using the method described in 
CHAPTER I (page no. 35). The following primary antibodies were used: rabbit anti-UT-A1 
(raised against the C-terminal of rat UT-A1, amino acids 911-929, Catalogue# SPC-406D, 
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1:200 dilution, StressMarq, Victoria, BC, Canada); goat anti-AQP2 (1:2000 dilution, Santa 
Cruz Biotechnology, Dallas, TX). Because the above UT-A1 antibody recognizes the C-
terminal of UT-A1, it also cross-reacts with UT-A2; however, the antibody would only bind 
with UT-A1 in the principal cells (marked by AQP2), which does not express any UT-A2.  
Statistical analyses 
Statistical analyses were performed as described in CHAPTER I (page no. 36). 
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Results 
EHD4-KO mice have a higher urinary urea excretion than WT mice 
Urinary urea excretion was significantly higher in both male and female EHD4-KO 
mice than that in WT mice (Fig. 30) when maintained on a regular rodent chow containing 
19% protein. The difference in urinary urea excretion in EHD4-KO was over twice than 
that in WT mice. Plasma urea concentration was slightly lower (~16% in males and ~10% 
in females) in EHD4-KO mice than WT mice (Fig. 31), but the difference did not reach 
statistical significance.  
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Figure 30: Effect of EHD4 deletion on urinary urea 
excretion. 24 h urinary urea excretion in male and female WT 
and EHD4-KO mice during standard rodent chow intake. All 
values are means ± SEM of n mice (in parentheses). Data were 
analyzed by 2-factor ANOVA, testing for main effects of 
genotypes (Pgenotype), sex (Psex), and the interaction between 
sex and genotype (Pinteraction). * P < 0.05 for EHD4-KO vs. WT 
mice of each sex, by post hoc test. 
Figure 30: Effect of EHD4 deletion on urinary urea excretion 
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Figure 31: Effect of EHD4 deletion on plasma urea 
concentration. Plasma urea concentration in male and 
female WT and EHD4-KO mice during standard rodent chow 
intake. All values are means ± SEM of n mice (in 
parentheses). Data were analyzed by 2-factor ANOVA, testing 
for main effects of genotypes (Pgenotype), sex (Psex), and the 
interaction between sex and genotype (Pinteraction). * P < 0.05 
for EHD4-KO vs. WT mice of each sex, by post hoc test.  
Figure 31: Effect of EHD4 deletion on plasma urea concentration 
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EHD4-KO mice showed an exaggerated diuretic response to high protein diet compared 
to EHD4-HOM mice 
When fed a 20% protein diet, both male and female EHD4-KO mice had higher 
urine flow and urinary urea excretion than EHD4-HOM mice (Fig. 32 and 33). In female 
mice, the differences in the urine flow (Fig. 32A) and urinary urea excretion (Fig. 32B) 
between EHD4-HOM and EHD4-KO mice were further increased during 40% protein diet 
intake. In female mice, 6% protein diet reduced the urine flow and urinary urea excretion 
in both EHD4-HOM and EHD4-KO mice such that these parameters were no longer 
significantly different (Fig. 32A and B).  
Both urine flow and urinary urea excretion remained higher in male EHD4-KO mice 
than EHD4-HOM mice when fed with 40% protein diet (Figure 33A and B). Moreover, both 
the urine flow and urinary urea excretion was higher in male EHD4-KO mice than EHD4-
HOM mice when fed with 6% protein diet (Figure 33A and 33B).  
Although the amount of food intake was similar in both male and female EHD4-
HOM and EHD4-KO mice for each particular diet, the total amount of food consumed 
declined as the protein content of the diet increased (Fig. 34A and 35A). Total protein 
intake was comparable between the two genotypes for each of the diets, with the 
exception of the female mice on the high protein diet (Fig. 34B and 35B). Protein content 
in the diet had a positive effect on the amount of water intake in both the genotypes (Pdiet 
< 0.05), resulting in an increase in amount of water consumed during high protein diet; 
however, the difference in the water intake between the EHD4-HOM and EHD4-KO mice 
remained comparable for each of the diets (Fig. 34C and 35C). The amount of water intake 
was significantly higher in male EHD4-KO mice than in EHD4-HOM mice when fed with 
6% protein diet (Fig. 35C). Changes in body weight in mice during each of the protein diets 
were comparable between the two genotypes in both the sexes (Fig. 34D and 35D).
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Figure 32: Effect of manipulation of dietary protein on renal 
urea handling in female mice. Data presented are 24 h urine 
flow (A) and urinary urea excretion (B) in female EHD4-HOM and 
EHD4-KO mice fed with 6%, 20%, and 40% protein diets. All 
values are means ± SEM of n mice (in parentheses). Data were 
analyzed by 2-factor ANOVA, testing for main effects of 
genotypes (Pgenotype), diet (Pdiet), and the interaction between diet 
and genotype (Pinteraction). * P < 0.05 for EHD4-KO vs. EHD4-HOM 
mice at a particular diet, by post hoc test. 
Figure 32: Effect of manipulation of dietary protein on renal urea handling in female 
mice 
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Figure 33: Effect of manipulation of dietary protein on 
renal urea handling in male mice. Data presented are 24 h 
urine flow (A) and urinary urea excretion (B) in male EHD4-
HOM and EHD4-KO mice fed with 6%, 20%, and 40% protein 
diets. All values are means ± SEM of n mice (in parentheses). 
Data were analyzed by 2-factor ANOVA, testing for main 
effects of genotypes (Pgenotype), diet (Pdiet), and the interaction 
between diet and genotype (Pinteraction). * P < 0.05 for EHD4-
KO vs. EHD4-HOM mice at a particular diet, by post hoc test.  
Figure 33: Effect of manipulation of dietary protein on renal urea handling in male
mice 
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Figure 34: Effect of manipulation of dietary protein on general metabolic parameters in 
female mice. Data presented are 24 h food intake (A), protein intake (B), water intake (C), and 
change in body weight in female EHD4-HOM and EHD4-KO mice fed with 6%, 20%, and 40% 
protein diets. All values are means ± SEM of n mice (in parentheses). Data were analyzed by 
2-factor ANOVA, testing for main effects of genotypes (Pgenotype), diet (Pdiet), and the interaction 
between diet and genotype (Pinteraction). * P < 0.05 for EHD4-KO vs. EHD4-HOM mice at a 
particular diet, by post hoc test. 
Figure 34: Effect of manipulation of dietary protein on general metabolic parameters in female mice 
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Figure 35: Effect of manipulation of dietary protein on general metabolic parameters in male 
mice. Data presented are 24 h food intake (A), protein intake (B), water intake (C), and change in body 
weight in male EHD4-HOM and EHD4-KO mice fed with 6%, 20%, and 40% protein diets. All values 
are means ± SEM of n mice (in parentheses). Data were analyzed by 2-factor ANOVA, testing for main 
effects of genotypes (Pgenotype), diet (Pdiet), and the interaction between diet and genotype (Pinteraction). * 
P < 0.05 for EHD4-KO vs. EHD4-HOM mice at a particular diet, by post hoc test.  
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Figure 35: Effect of manipulation of dietary protein on general metabolic parameters in male mice 
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Tissue osmolality and tissue urea concentration in EHD4-KO mice were comparable to 
those in EHD4-HOM mice when fed with 20% protein diet 
In mice maintained on a 20% protein diet, there was a gradient of increasing tissue 
osmolality from renal cortex to the inner medulla in both male and female EHD4-HOM and 
EHD4-KO mice (Figure 36A and 37A) (Ptissue < 0.0001). Deletion of EHD4 did not have a 
significant effect on tissue osmolality in either sex (Pgenotype > 0.05). Tissue urea 
concentration also exhibited a similar increasing gradient as the tissue osmolality, with the 
highest concentration present in the inner medulla (Ptissue <0.0001) (Fig. 36B and 37B). 
The tissue urea concentration across the three kidney regions were comparable in both 
the genotypes (Fig. 36B and 37B).  
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Figure 36: Role of EHD4 in the regulation of renal osmotic 
gradient in female mice. Data presented are tissue osmolality 
(A) and tissue urea concentration (B) in female EHD4-HOM and 
EHD4-KO mice fed with 20% protein diet. All values are means 
± SEM of n mice (in parentheses). Data were analyzed by 2-
factor ANOVA, testing for main effects of genotypes (Pgenotype), 
renal region (Pregion), and the interaction between diet and 
genotype (Pinteraction).  
Figure 36: Role of EHD4 in the regulation of renal osmotic gradient in female mice 
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Figure 37: Role of EHD4 in the regulation of renal 
osmotic gradient in male mice. Data presented are 
tissue osmolality (A) and tissue urea concentration (B) in 
male EHD4-HOM and EHD4-KO mice fed with 20% 
protein diet. All values are means ± SEM of n mice (in 
parentheses). Data were analyzed by 2-factor ANOVA, 
testing for main effects of genotypes (Pgenotype), renal 
region (Pregion), and the interaction between diet and 
genotype (Pinteraction).  
A 
B 
Figure 37: Role of EHD4 in the regulation of renal osmotic gradient in male 
mice 
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Cellular distribution of UT-A1 appeared more peri-nuclear in EHD4-KO mice than in WT 
mice  
Higher urea excretion in EHD4-KO mice could arise from a reduced cellular 
abundance of UT-A1 in the inner medulla. To test if UT-A1 was lower in the EHD4-KO 
mice than in WT mice, the total abundance of UT-A1 in the inner medulla was examined. 
Immunoblotting revealed no difference in the overall UT-A1 abundance between the two 
genotypes (Fig. 38). To investigate if the apical membrane accumulation of UT-A1 was 
reduced in the EHD4-KO mice, the cellular localization of UT-A1 in principal cells of the 
IMCD was studied using immunofluorescence staining. Tissues were co-stained with 
AQP2 antibody to mark principal cells, which express UT-A1 and UT-A3. The antibody 
used for staining recognizes the C-terminal of UT-A1, which allows for the visualization of 
only UT-A1 in these principal cells. Qualitative analysis of UT-A1 staining revealed 
increased staining of UT-A1 in EHD4-KO mice than in WT mice (Fig. 39). Moreover, UT-
A1 in EHD4-KO mice appeared to be localized more towards the nucleus, whereas it was 
more towards the apical membrane in the WT mice.  
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Figure 38: Effect of EHD4 deletion on the total 
cellular abundance of UT-A1. Representative 
immunoblot and densitometric quantification of UT-A1 in 
IM of female WT and EHD4-KO mice. All values are 
means ± SEM of n mice (in parentheses). Data were 
analyzed by unpaired t test.
Figure 38: Effect of EHD4 deletion on the total cellular abundance of UT-
A1 
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WT EHD4-KO 
Figure 39: Effect of EHD4 deletion on the cellular localization of UT-A1. 
Representative immunofluorescent images of UT-A1(red) in IM of female WT and 
EHD4-KO mice (n = 4 per group; 3 images per animal). Samples were co-stained 
with AQP2 (green) to identify principal cells in the IM. Gain settings for red channel 
was intensified to visualize UT-A1 in the WT samples, and was maintained at the 
same level during analysis of EHD4-KO samples. Enlarged image of a tubule from 
each genotype is shown in the inset. Scale bar, 10 μm.
Figure 39: Effect of EHD4 deletion on the cellular localization of UT-A1 
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Discussion 
This study focused on the role of EHD4 in the regulation of renal urea handling. 
EHD4-KO mice develop a diuretic phenotype that is very similar to that observed in mice 
lacking UT-A1/A3, including high urine flow and reduced urine osmolality, thereby 
suggesting a potential role of EHD4 in urea handling. In line with the hypothesis, a 
significantly higher urea excretion was observed in EHD4-KO mice than both WT and 
EHD4-HOM mice when fed with rodent chow containing a normal protein content (either 
19 or 20%). Increasing protein content in the diet to 40% further increased the urine flow 
and urinary urea excretion in EHD4-KO mice compared to EHD4-HOM mice, and at least 
in females, the diuretic phenotype was attenuated in EHD4-KO mice when fed with 6% 
protein diet. Although EHD4 may not be involved in the generation and preservation of the 
renal osmotic gradient in mice fed with 20% protein diet, the preliminary data on UT-A1 
localization suggest a potential role of EHD4 in the regulation of UT-A1. Thus, I conclude 
that the diuretic phenotype in EHD4-KO mice may be partially attributable to defective 
urea handling in the kidney. 
Urea handling in the kidney is an important regulator of the urine-concentrating 
mechanism, allowing the kidney to produce a hyperosmotic urine. Most of the current 
understanding on the role of urea in urine-concentrating mechanisms derive from the 
fundamental urea handling model proposed by Berliner in the late 1950s (8). In this 
elegant model, Berliner described that the urea accumulation in the IMCD does not evoke 
osmotic diuresis due to the high urea permeability of the IMCD that results from the 
presence of urea transporters. Indeed, dysregulation of renal urea handling in the IMCD, 
such as during the absence of functional urea transporters UT-A1/A3, has been shown to 
impact the ability to properly concentrate urine (44, 45). These studies have reported that 
UT-A1/A3 double knockout mice develop severe polyuria without any aberrant renal 
125 
 
morphology (159), comparable to what has been observed in EHD4-KO mice. Consistent 
with these observations, EHD4-KO mice was found to have an increased urinary urea 
excretion compared to WT mice, almost twice than that in WT mice.  Moreover, the plasma 
urea concentration was also slightly reduced in EHD4-KO mice (~10-16%), which is 
consistent with urea wasting and also suggests that the increased urea excretion in the 
EHD4-KO mice is not due to increased production of urea.  
The excretion of urea by the kidney is thought to be dependent on two factors: the 
filtered load of urea and the amount of urea reabsorbed along the nephron. Increased 
urinary urea excretion in EHD4-KO mice may possibly arise due to a reduced reabsorption 
of urea in the IMCD, where EHD4 is abundantly expressed. Urea reabsorption in the IMCD 
occurs in two steps: entry of urea from the luminal fluid into the principal cells via UT-A1 
followed by exit into the renal interstitium via the UT-A3 in the basolateral side. The cellular 
abundances of both UT-A1 and UT-A3 are regulated by various cellular mechanisms, 
including endocytosis (11, 186). The polyuria observed in EHD4-KO mice is similar to that 
observed in mice lacking both UT-A1 and UT-A3 (45). In these UT-A1/A3 double knockout 
mice, transgenic overexpression of UT-A1 restores the diuretic phenotype, suggesting that 
UT-A1 is necessary for basal maximal urinary concentration (92), a parameter which is 
also defective in EHD4-KO mice. Therefore, it could be possible that in EHD4-KO mice 
the amount of UT-A1 may be reduced in the IMCD, causing reduced urea reabsorption in 
the IMCD. Proteins from the UT-A family share a high degree of sequence homology 
because they are splice variants derived from the same gene (175), making it quite 
challenging to accurately identify and quantify these transporters in the renal tissues by 
immunostaining. An antibody raised against the C-terminal of the parent UT-A protein was 
used that recognizes UT-A1 (expressed in the IMCD), UT-A2 (expressed in the thin 
descending limb), and UT-A4 (expressed in the IMCD of rat, not mouse). The bands 
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around ~97 kD were identified as UT-A1, similar to what has been reported previously 
(12). Western blotting of inner medulla for total UT-A1 did not show any statistically 
significant difference in the abundance of UT-A1 between EHD4-KO and WT mice. 
Because total cellular abundance of a protein does not indicate its abundance in the 
membrane, immunofluorescence staining was employed to examine the cellular 
localization of UT-A1. Using a commercially available UT-A1 antibody that recognizes the 
same epitope of UT-A1, a dramatic and contrasting difference in the staining intensity of 
UT-A1 between the two genotypes was observed. UT-A1 staining appeared more intense 
and peri-nuclear in EHD4-KO mice than that in WT mice. These results, albeit conflicting 
with the Western blot data, suggest a potential role of EHD4 in the regulation of UT-A1 
trafficking in the principal cells. Future studies involving UT-A1-transfected principal cell 
line would be needed to probe further into the role of EHD4 in UT-A1 trafficking. Such a 
set up would allow us to understand the role of EHD4 in the trafficking of UT-A1 specifically 
in the principal cells and allow us to identify if and how EHD4 regulates UT-A1. 
In the liver, catabolism of amino acids derived from dietary protein generates urea, 
which is then excreted by the kidney. The filtered load of urea in the kidney is, therefore, 
in part dictated by the amount of dietary protein. In his urea-handling model (8), Berliner 
had proposed that in the setting of dysfunctional urea transportation in the IMCD, an 
increased filtered load of urea would result in a urine-concentrating defect. This urine-
concentrating defect would arise because less urea would be reabsorbed from the tubular 
lumen, which would increase the amount of urea in the lumen and therefore result in urea-
induced diuresis. He further described that this urine-concentrating defect would be 
subsequently reversed when the filtered urea load is reduced. It is currently hypothesized 
that the high urea excretion in EHD4-KO mice is at least partly due to a defective urea 
reabsorption in the IMCD. Hence, I proceeded to test this hypothesis further using the 
127 
 
aforementioned model of manipulating filtered urea load with dietary protein. When fed 
with 40% protein diet, there was a further increase in the urine flow and urinary urea 
excretion in both male and female EHD4-KO mice. In female mice particularly, the shift 
from 20% to 40% protein diet resulted in a greater differences in those renal parameters 
between the EHD4-HOM and EHD4-KO mice. However, the difference in the urine flow 
and urea excretion between the two female genotypes were comparable when the diet 
was switched to 6% from 40% protein. The disappearance of differences in these renal 
parameters in the female mice suggest that EHD4-KO mice could effectively reabsorb 
enough urea from the tubule via the available UT-A1 in the membrane when urea load is 
reduced. These findings are in line with Berliner’s urea-handling model, and the data 
strongly suggest that EHD4 regulates urea handling in the kidney. Moreover, the 
exaggerated diuretic response to high protein diet in EHD4-KO mice is very comparable 
to that seen in UT-A1/A3 double knockout mice (45). In these UT-A1/A3 double knockout 
mice, the diuretic phenotype is restored when UT-A1 is transgenically overexpressed in 
these mice (92), showing that UT-A1, and not UT-A3, is required for basal urine-
concentrating ability. Therefore, the current working hypothesis is that in EHD4-KO mice, 
the accumulation of UT-A1 in the apical membrane of principal cells is reduced. This 
reduction causes a decrease in the amount of urea that can be reabsorbed in the IMCD, 
thereby resulting in an accumulation of urea in the tubular lumen. Because of this urea 
accumulation, EHD4-KO mice develop urea-induced diuresis. Although the 
immunofluorescence staining of UT-A1 in the kidney sections suggested increased peri-
nuclear localization of UT-A1 in EHD4-KO mice, the results are inconclusive. The role of 
EHD4 in regulating apical UT-A1 localization require further analysis, such in a cell culture 
model. 
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Modulation of filtered urea load via modification of dietary protein intake is a model 
that has been used successfully in many previous studies to understand renal urea 
handling (44, 45, 47); however, I became aware of the limitations of this model during 
these experiments. One of the unexpected results of this study was the discovery of a sex 
difference in the response to 6% protein diet. In male mice, both the urine flow and urinary 
urea excretion was further elevated in both the genotypes during 6% protein intake. The 
increased diuresis was matched by an increase in water intake. It has been previously 
reported by others that low protein diet triggers a urine-concentrating defect in rats (76, 
77) and it is proposed that this defect arises in an attempt to conserve nitrogen in the body. 
It is possible that in the male mice low protein intake triggers a metabolic stress response 
to allow the urea to be recycled back to the liver to conserve nitrogen. In doing so, the 
renal urea gradient is compromised and the tissue osmotic gradient is washed out, 
resulting in a urine-concentrating defect. Recent studies have shed some light on how 
protein restriction may stimulate the integrated stress response pathways (97-99). A 
recent study has shown that these pathways are more active in female mice than in males 
during amino acid-restricted diet (105), providing a better adaptive capacity in females 
during amino acid restriction. It is possible that female mice can adapt faster to the low 
protein diet and overcome the nitrogen deficit faster than male mice, thereby not showing 
the urine-concentrating defect. Another reason for the urine-concentrating defect in male 
mice could be due to a residual effect of the high protein diet. Because the diets in the 
mice were switched from 40% to 6%, it is possible that some of the effects of the 40% 
protein diet could have been retained in the male mice, thereby causing diuresis. In future, 
a better approach to rule out this residual effect of 40% protein diet would be to step down 
the protein level gradually to 20% and then to 6% protein. Probing into the role of EHD4 
in renal urea handling in mice maintained on 6% protein diet and understanding the effect 
of sex on renal urea handling are some of the exciting future directions for this work. 
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Urea undergoes a significant amount of recirculation in the kidney that allows for 
the sequestration of urea in the renal medulla (102). The disproportional reabsorption of 
water and urea results in a high concentration of urea in the fluid that arrives in the IMCD. 
This mechanism allows urea to diffuse into the interstitium via UT-A1 and UT-A3, thereby 
resulting in an accumulation of urea in the inner medulla of the kidney. This accumulated 
urea in the inner medulla, however, may escape into the blood via the ascending vasa 
recta. This risk is overcome by the parallel and close arrangement of the vasa recta and 
the tubules that allows the urea to be recycled back into the descending vasa recta (via 
UT-B) and into the descending thin limbs (via UT-A2). Therefore, urea recycling within the 
renal interstitium helps in the generation and maintenance of the osmotic gradient required 
for concentrating urine. The current data suggest that the generation and preservation of 
the renal tissue osmolality and urea concentration is independent of EHD4. Moreover, 
there was no difference in the amount of tissue urea between EHD4-HOM and EHD4-KO 
mice, even though the functional data suggests a role of EHD4 in the reabsorption of urea. 
Previous studies have reported compensatory upregulation of urea transporters in the 
absence of one or more urea transporters in mice (90). In one particular study (90) with 
UT-B knockout mice, there was almost a 120% increase in the abundance of UT-A2 in the 
outer medulla, indicating that mice are capable of an adaptive response to the loss of a 
urea transporter that may allow them to maintain a functional intrarenal urea recycling 
pathway.  Despite a high urea excretion, EHD4-KO mice may be able to maintain a steady 
urea concentration possibly by increasing the recycling of urea between the vasculature 
and tubule. EHD4-KO mice indeed have a slightly reduced plasma urea level than WT 
mice, suggesting that may be there is an increased recycling of urea via UT-B from the 
vasa recta into the inner medulla. The expression profiles of other renal urea transporters 
will need to be assessed in order to fully understand how EHD4-KO mice are able to 
preserve the osmotic gradient in the kidney despite high urea excretion. One of the major 
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technical difficulties with studying each of these urea transporters is the lack of specific 
commercial antibodies for each of the urea transporters. The available antibodies in the 
market cross-react with the other isoforms, making quantitative analysis difficult to 
perform. 
Most of the current understanding of renal urea handling are based on hypothetical 
models proposed by various groups, and ongoing studies have helped shed light on the 
complexity of the process. These data strongly suggest a role of EHD4 in the regulation 
of renal urea handling. In the light of the current data, wherein high levels of EHD4 
expression are found in the IMCD, it is hypothesized that EHD4 is most likely to regulate 
the reabsorption of urea in the IMCD; however, the exact role of EHD4 in the regulation 
renal urea handling remains unclear. As mentioned before, RNA sequencing data has 
shown that EHD4 is also expressed in the thin limbs, so it is also possible that EHD4 may 
regulate UT-A2 in the thin limbs.  The working hypothesis is that EHD4 regulates the 
membrane accumulation of UT-A1 in the IMCD. A lack of EHD4 in mice reduces the 
membrane accumulation of these urea transporters in the IMCD, thereby reducing 
urea reabsorption and causing a urea-induced osmotic diuresis.  
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DISCUSSION 
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Major findings of the dissertation 
The experiments performed in this dissertation have provided novel insights into 
the physiological and cellular role of a regulator of endocytic recycling. Endocytic recycling 
is an important cellular mechanism that is involved in the regulation of extracellular fluid 
osmolality (46, 75). EHD4 regulates endocytic recycling, but the specific role of EHD4 
pertaining to renal water and solute handling remains largely unknown. The overall aim of 
this dissertation was to elucidate the role of EHD4 in the kidney in order to bridge some of 
the gap in the knowledge of cellular machinery involved in the regulation of renal channels 
and transporters. This dissertation described for the first time a role of EHD4 in the 
regulation of trafficking of AQP2 and AQP4 in principal cells, and recycling of urea in the 
kidney. This study provides important insights on the cellular machineries of the endocytic 
recycling process in the kidney, and shows how the lack of a regulator of endocytic 
recycling can have a profound effect on the kidney’s ability to handle water and urea. 
This study has shown for the first time that EHD4 is an important regulator of urine 
formation and composition.  A major finding of this study has been the discovery that EHD4 
regulates renal water handling, and in its absence EHD4-KO mice were found to develop 
a diuretic phenotype. Experiments from Chapter I revealed that EHD4 is required for the 
control of basal and maximal urine concentration, and anti-diuretic responses during 24-h 
water restriction is independent of EHD4. Data gathered in Chapter I also revealed that 
EHD4 might not regulate the central release of AVP in mice. Additionally, in Chapter III 
EHD4 was discovered to be involved in the regulation of renal urea handling, a complex 
physiological process that is crucial for concentrating urine. Albeit weak, current data 
suggest a potential role of EHD4 in the regulation of UT-A1 cellular localization in principal 
cells.   
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Investigations in Chapter II revealed that EHD4 regulates the membrane 
abundance of both AQP2 and AQP4 in their respective membranes in principal cells. 
Although several studies have identified and isolated protein complexes found within 
AQP2-containing vesicles in principal cells, very limited information is available regarding 
the exact role of these proteins in the actual trafficking event. Studies in Chapter II of this 
dissertation have addressed how EHD4 may regulate AQP2 trafficking, and shown that 
EHD4 reduces the accumulation of glycosylated AQP2 in the apical membrane of principal 
cells. Both Chapters I and II strongly indicate that EHD4 may not be involved in the 
classical AVP-mediated regulation of AQP2 trafficking, and may regulate the constitutive 
recycling of AQP2, an avenue that currently remains largely unexplored in the scientific 
world. Moreover, almost no information is currently present regarding the trafficking of 
AQP4 in the kidney. A novel and valuable finding of Chapter II of this dissertation has been 
the discovery of the role of EHD4 in the regulation of AQP4 trafficking to the basolateral 
membrane in principal cells. Deletion of EHD4 reduces the membrane abundance of 
AQP4 in the basolateral membrane of principal cells, which possibly contributes to the 
diuretic phenotype of the EHD4-KO mice.   
In addition, this work also provided evidences supporting the role of EHD4 in the 
regulation of synthesis of PGE2. This finding provides a possible mechanism of regulation 
of AQP2 and/or UT-A1 trafficking in the principal cells via EHD4. Moreover, there was a 
lack of evidence to support a role of EHD4 in the regulation of renal sodium handling. 
Taken together, these findings indicate that EHD4 regulates renal water handling, and 
therefore plays an important role in the formation of urine and its composition. My 
current working hypothesis is that EHD4 regulates urine formation and composition 
by regulating the cellular trafficking of AQP2, AQP4, and UT-A1. Figure 40 
summarizes these major findings.    
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Figure 40: Representative figure of the major findings of this study. Global deletion 
of EHD4 in mice results in increased urine flow, reduced urine osmolality, and increased 
urea excretion. Data generated during this study (dashed lines) has shown the role of 
EHD4 in the regulation of membrane accumulation of AQP2, AQP4, and UT-A1, and 
the generation of PGE2 in principal cells. EHD4 has also been found to co-localize with 
AQP2 in cultured principal cells, but immunoprecipitation data suggest a lack of direct 
physical interaction between the two proteins. Deletion of EHD4 increases the 
production of PGE2 both in vivo and in vitro. One way PGE2 reduces membrane 
accumulation of AQP2 in principal cells is via the inhibition of AQP2 recycling (solid 
line), which has been reported in previous studies (148). Therefore, it is hypothesized 
that EHD4 deletion results in an increase in PGE2, which in turn may stall the recycling 
of AQP2 in principal cells. 
Figure 40: Representative figure of the major findings of this study 
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Potential mechanisms underlying the effect of EHD4 on the subcellular localization 
of AQP2 
A defect in urine-concentrating mechanism may arise due a faulty renal water 
handling. Fine-tuning of water reabsorption occurs exclusively in the collecting duct, where 
membrane abundance of the aquaporin water channels of the principal cells determine 
the water permeability of the collecting duct. The role of EHD4 in the regulation of the 
cellular localization of the aquaporin channels of the IMCD are discussed in the following 
section. 
Role of EHD4 in the regulation of post-translational modifications of aquaporins of the 
principal cells 
The aquaporin water channels of the principal cells, namely AQP2, -3, and -4, 
regulate the water permeability of the collecting duct. AQP3 and -4 are constitutively 
expressed in the basolateral membrane of principal cells, whereas expression of AQP2 in 
the apical membrane is regulated. It was found that EHD4 deletion reduces the amount of 
AQP2 in the apical membrane of principal cells of IM in mice (Fig. 16). Additionally, using 
a cultured principal cell line, it was also found that EHD4 regulates the accumulation of 
glycosylated AQP2 in the apical membrane of principal cells (Fig. 22), indicating a 
potential role of EHD4 in regulating the glycosylation process of AQP2. EHD4 does not 
appear to influence the abundance and localization of non-glycosylated-AQP2. 
Glycosylation of membrane proteins occur in the rough ER (197) and a distinct peri-
nuclear localization of EHD4 was observed in the cultured principal cells (Fig. 24 and 25), 
thereby raising the possibility that EHD4 to regulate the glycosylation process of AQP2.  
Additional evidence supporting this notion comes from the data on AQP4 expression in 
EHD4-KO mice. In the absence of EHD4, the amount of AQP4 is significantly reduced in 
the basolateral membrane (Fig. 18), and immunoblotting revealed a reduced expression 
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of glycosylated-AQP4, and not the non-glycosylated form. Together, these data on AQP2 
and AQP4 suggest a role of EHD4 in the glycosylation of these membrane proteins, and 
the specific role of EHD4 in the regulation of glycosylation of membrane proteins remains 
to be tested in future.  
Potential cellular mechanisms by which EHD4 regulates apical membrane abundance of 
AQP2 
EHD proteins usually interact with their partner proteins via an interaction between 
EH-NPF motifs (135). AQP2 lacks an NPF motif, therefore the chances of a direct physical 
interaction between AQP2 and EHD4 is small. Moreover, EHD4 was not found in the 
immunoprecipitate complex containing AQP2 (Fig. 26), suggesting a lack of direct physical 
interaction between the two proteins. However, EHD4 was found to co-localize with AQP2 
(Fig. 25), thereby providing a high possibility for these proteins to interact in some indirect 
way. A better approach in understanding the exact nature of the interaction between EHD4 
and AQP2 would be to transfect principal cells with constructs containing specific domains 
of EHD4 and then testing to see if AQP2 can be found in the pulled down complexes. 
Data from both in vivo and in vitro models show that EHD4 deletion reduces the 
accumulation of AQP2 in the apical membrane of principal cells. EHD4 is known to 
regulate the early endosomal trafficking of membrane proteins (178) and in principal cells, 
it was observed that EHD4 localized near the plasma membrane (Fig. 24 and 25), where 
early endosomes would be found. These data indicate that one way EHD4 possibly 
regulates the membrane activity of channels and transporters in principal cells is by 
regulating the early endosomal trafficking. The protein-protein interaction profile predicts 
that EHD4 interacts with early endosomal proteins called Rab5 (Fig. 23). It has been 
reported previously that when EHD4 is absent, the activity of Rab5 increases (178), which 
in turn may increase early endosomal traffic. Therefore, it is possible that the reduced 
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membrane abundance of AQP2 in the absence of EHD4 could arise due to increased 
uptake into the early endosome combined with a reduced entry to the recycling endosome. 
Sorting of proteins in the early endosome is a highly dynamic process and involves 
coordinated activity of several proteins, including EHD4 (81). Because early endosomal 
sorting is dynamic, it would require a robust live-cell imaging technique involving pulse-
chase experiments with labelled compounds to follow the dynamics of the traffic of AQP2 
through the endosomal system in the principal cell when EHD4 is absent. Such an 
approach in the future would certainly allow accurate identification of the role of EHD4 in 
the regulation of AQP2 trafficking, but it was beyond the scope of the current project. 
Another possible reason behind the reduced membrane accumulation of AQP2 in 
EHD4-depleted cells could be due to reduced entry of AQP2 into the recycling endosome. 
Under basal conditions, AQP2 is known to undergo constitutive recycling (112) and one 
of the major proteins that regulate the shuttling of AQP2 to and from the recycling 
endosome is Rab11-Fip2 (137). Rab11-Fip2 is known to interact with EHD proteins (136), 
therefore it is possible that Rab11-Fip2 may be a common interacting partner between 
AQP2 and EHD4. Studies with EHD3 have shown that the interaction between EHD3 and 
Rab11-Fip2 is required for the entry of internalized cargo into the recycling endosome 
(136). Although interaction between EHD4 and Rab11-Fip2 has not been studied, it is 
possible that, in the absence of EHD4, the interaction between AQP2 and Rab11-Fip2 
may be lost, thereby resulting in reduced entry of AQP2 into the recycling endosome. Due 
to the lack of a Rab11-Fip2 antibody that works with co-immunoprecipation, this 
hypothesis remains to be tested using alternative techniques such as yeast-two hybrid 
binding assay in the future. 
Although it is possible that the effect of EHD4 on AQP2 is mediated by physical 
interactions, it is also very likely that some alternative mechanisms that regulates AQP2 
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is altered in EHD4-depleted cells. One pathway that was found to be upregulated in EHD4-
depleted cells was the synthesis of PGE2 (Fig. 27 and 29). The recycling of AQP2 is 
negatively regulated by PGE2, so it is quite possible that EHD4 regulates AQP2 recycling 
in a PGE2-dependent manner. 
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Physiological roles of EHD4 in the regulation of renal function 
Studies performed over several decades have already established the importance 
of endocytic recycling in the regulation of renal function (75). It was, therefore, not 
surprising when expression profiling of EHD proteins across tissues revealed the presence 
of EHD4 in the kidney (58). However, the specific role of EHD4 in the kidney remained 
unknown, and only very recently a role for EHD proteins in the glomerular 
microvasculature had been reported (56), but nothing is known regarding the functional 
role of EHD4 or other EHDs in the tubular system. The overall objective of the work 
contained in this dissertation has been to elucidate the physiological roles of EHD4 in the 
regulation of renal function, and to shed some light on to the cellular processes regulated 
by EHD4 in the kidney.  
In order to better understand the exact role of EHD4 in the kidney, it was important 
to identify the sections of the kidney where EHD4 is expressed. It was found that, among 
all the nephron sections that could be isolated, EHD4 is expressed the most in the IMCD 
(Fig. 1). This part of the kidney is exquisitely involved in the fine-tuning of urine formation 
and its final composition. Consistent with this expression profile, it was found that EHD4-
KO mice have a higher urine flow and lower urine osmolality than WT mice (Fig. 5). This 
diuretic phenotype in EHD4-KO mice suggests that EHD4 is important for regulating 
urinary water homeostasis. At the level of the kidney, water homeostasis is maintained by 
two major urine-concentrating mechanisms- 
1.  Increased permeability of the collecting duct to water, which depends on a 
functional AVP-AQP2 axis between the hypothalamus and the kidney. 
2. High osmolality of the renal medullary interstitial fluid, which depends on effective 
renal water, sodium, and urea handling mechanisms. 
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I explored the roles of EHD4 in the regulation of both of these major physiological 
processes. 
Role of EHD4 in the regulation of the hypothalamic-renal feedback mechanisms 
Formation and concentration of urine in the kidney depends on the feedback 
mechanisms involving the hypothalamus (central component) and the kidney (renal 
component) (75). These central and renal components form the regulatory axis that 
maintains water balance during variations of water intake and water loss.  Along with being 
expressed in the IMCD, EHD4 was also found to be expressed in the hypothalamus (Fig. 
11); however, the exact cell type that expresses EHD4 is not currently known and this was 
a crude attempt to investigate whether EHD4 is expressed in the hypothalamus. These 
data suggest that EHD4 could be involved in the regulation of the central and/or renal 
components of water balance. The interpretation that the diuretic phenotype is due to 
defective renal water handling rather than primary polydipsia derives primarily from the 
observations made during the acute water loading experiments (Fig. 6) as well as the 
subcellular localization of AQP2 (Fig. 16). An i.p. injection of water allowed us to bypass 
the oral route of water intake. This approach provided a way to assess the role of EHD4 
in eliminating a water load without the influence of the thirst mechanism mediated via the 
central regulatory component of water homeostasis. As shown in figure 6, the diuretic 
response to an acute water load in EHD4-KO mice was significantly larger than that in WT 
mice. The exaggeration of the diuretic phenotype in EHD4-KO mice after the water load 
suggested that the renal component of water homeostasis may be compromised in EHD4-
KO mice.  
It has been long known that an increase in plasma osmolality is a strong stimulation 
for the secretion of AVP from the hypothalamus (35). Secreted AVP from the 
hypothalamus enters the blood circulation and increases the water permeability of the 
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collecting duct of the kidney to allow concentration of urine (93, 139). A series of 
observations in EHD4-KO mice so far has led us to believe that the diuretic phenotype of 
the EHD4-KO mice is not attributable to a central effect of loss of EHD4, given that the 
role of EHD4 in the hypothalamus is unclear at this point. Firstly, the plasma osmolality of 
EHD4-KO mice was similar to that in WT mice (Fig. 12A), indicating an ability to conserve 
water balance even in the light of the diuresis. Secondly, it was also found urinary AVP 
excretion to be similar between the two genotypes (Fig. 12B). Urinary AVP excretion is 
not a direct measurement of the circulating AVP, but it has been successfully used before 
(53, 69) as a surrogate marker for circulating AVP. Similarity of AVP excretion between 
the two groups indicate that the effect of EHD4 deletion on the regulation of AVP release 
from the hypothalamus is either negligible or masked by another compensatory 
mechanism. Indeed, the expression of EHD1 in the hypothalamus increases significantly 
in EHD4-KO mice (Fig. 11B). EHD proteins possess a high degree of homology with each 
other (134) and have been reported to compensate for each other in previous studies (56). 
Therefore, it is possible that the effect of EHD4 deletion on the central component remains 
masked due to EHD1, which allows keeping AVP secretion, and in turn plasma osmolality, 
constant despite the diuresis. The upregulation of EHD1 in the hypothalamus of EHD4-
KO mice suggests that EHD4 has a necessary functional role in the hypothalamus, which 
remains to be tested. Thirdly, the mismatch between water intake and urine volume in 
EHD4-KO mice was greater than WT mice (Fig. 4A and 5A), suggesting that polydipsia 
may not be the primary cause of this diuretic phenotype in EHD4-KO mice. This 
observation further provides more evidence for a renal defect rather than a defect in the 
central component; however, more experiments, such as studying the response of EHD4-
KO mice to dipsogenic agents, will be needed to elucidate the exact role of EHD4 in the 
thirst mechanism.   
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Role of EHD4 in the regulation of renal AVP-AQP2 axis 
Multiple lines of evidence suggest that the AVP-AQP2 axis remains functional in 
EHD4-KO mice. No difference in the cellular abundance of pAQP2 was found between 
WT and EHD4-KO mice under baseline conditions (Fig. 17A), which indicates a functional 
AVP-AQP2 axis in EHD4-KO mice. Moreover, EHD4-KO mice were found to exhibit similar 
anti-diuretic responses as WT mice during 24-h water restriction (Fig. 7). AVP is the major 
anti-diuretic agent released during water deprivation (49) and allows conservation of water 
by increasing water permeability of the collecting duct. AVP increases the phosphorylation 
of AQP2 (144), resulting in an increase in the membrane accumulation of AQP2. Both the 
abundance and the membrane availability of AQP2 increased in a similar way in both WT 
and EHD4-KO mice post-water restriction (Fig. 8). These observations strongly indicate 
that the AVP-AQP2 axis in the kidney remains intact even in the absence of EHD4.  
The role of the AVP-AQP2 axis in the regulation of water permeability of the IMCD 
comes into play when plasma osmolality increases, such as during water restriction. 
EHD4-KO mice showed a similar anti-diuretic response to 24-h water restriction as WT 
mice. This data, along with the other observations discussed in the previous section, 
suggest that this AVP-AQP2 axis is functional in the absence of EHD4. Moreover, the 
diuresis in EHD4-KO mice is more prominent under baseline conditions, and urine-
concentrating abilities seemed to be functional during water restriction. Although EHD4-
KO mice were able to concentrate their urine post water restriction, the urine osmolality of 
EHD4-KO mice remained significantly lower compared to WT mice (Fig. 7B). This 
suggests that EHD4 is required for maximal urine-concentrating ability. Therefore, it is 
possible that the diuretic phenotype in EHD4-KO mice is more of a baseline defect, which 
can be overcome during anti-diuresis. 
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EHD proteins have been reported previously to exhibit compensatory roles for one 
another when one of the members is absent (56). Consistent with this, there was an 
increased expression of EHD1 in the hypothalamus in the absence of EHD4 in mice (Fig. 
11B). Hence, it is possible that the urine-concentrating ability in EHD4-KO remains 
functional due a compensatory upregulation of other EHD proteins. No such increase in 
the expressions of EHD1, -2, and -3 in the renal tissues of EHD4-KO mice after 24-h water 
restriction was observed (Fig. 10), suggesting that the anti-diuretic response to water 
restriction occurs in an EHD-independent manner. All these observations suggest that 
EHD4 has a role in the regulation of renal water reabsorption during baseline conditions, 
whereas key physiological mechanisms allowing for increases of urinary concentration 
under conditions of water restriction remain intact. 
Role of EHD4 in the regulation of renal osmotic gradient 
In order for the kidney to generate a hyperosmotic urine, it needs to maintain a 
hyperosmolar environment in the renal medulla. Two major processes in the renal medulla 
contribute to the generation of the osmotic gradient: active transport of sodium ions via 
the NKCC2 in the MTAL, and the facilitated diffusion of urea through the urea transporters 
of the IMCD. It was found that both MTAL and IMCD expresses EHD4 (Fig. 1), and 
therefore, it is possible that EHD4 regulates the generation of the osmotic gradient by 
influencing either or both of these two processes at these sites. The data on the NKCC2 
expression and responses to acute furosemide injection suggest that EHD4 may not be 
involved in the regulation of sodium transport via NKCC2 (Fig. 15). However, it is possible 
that the effect of EHD4 deletion on sodium reabsorption via NKCC2 may be masked by 
the compensatory upregulation of the activities of other medullary sodium 
channels/transporters, such as ENaC activity in principal cells. It has been previously 
reported that a chronic administration of furosemide in rats result in an increases in ENaC 
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abundance (131) that results in the generation of tolerance to diuretics. My attempt to 
understand this phenomenon remained largely unsuccessful and inconclusive because of 
the failure of amiloride to generate a natriuretic effect (Fig. 14). ENaC is responsible for 
only a small percentage of total Na reabsorption, perhaps contributing to the difficulty in 
detecting an effect in conscious mice Although the abundance of αENaC was not different 
between WT and EHD4-KO mice, it is still possible that the activity or membrane 
abundance of ENaC, as well as NKCC2, may be compromised in EHD4-KO mice. 
Endocytic recycling is known to regulate the membrane abundance of both ENaC (19, 20, 
37) and NKCC2 (1, 21). Indeed, SNAP29, one of the predicted interacting partners of 
EHD4 (found through STRING analysis) (Fig. 23), has been identified in vesicles involved 
in NKCC2 trafficking (21). Despite the expression of EHD4 in these segments where 
NKCC2 and ENaC are expressed, the exact role of EHD4 in the regulation of these 
channels and transporters remain unclear. One way to understand if EHD4 regulates 
either or both NKCC2 and ENaC would be to study the effect of EHD4 deletion on the 
membrane accumulation of these channels and transporters in appropriate cultured cells. 
The renal osmotic gradient is generated by the buildup of solute concentration, 
particularly sodium and urea. It was found that the osmotic gradient across the renal 
interstitium was similar between EHD4-HOM and EHD4-KO mice (Fig. 36A and 37A). On 
a first glance, this data would seem to indicate that the maintenance of the renal osmotic 
gradient is independent of EHD4, which may be true. However, the generation and 
preservation of this osmotic gradient is a complex process, and EHD4 may be involved in 
the regulation of this process in a way that may not be readily apparent from the current 
data. Urea reabsorption and recycling within the IM are important factors for maintaining 
the renal osmotic gradient. Tissue urea concentration of EHD4-KO mice was found to be 
similar to that in EHD4-HOM mice (Fig. 36B and 37B). These data indicate that, along with 
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tissue osmolality, preservation of tissue urea gradient may also be EHD4-independent. 
However, it was also found that in the absence of EHD4, urinary urea excretion is 
increased and plasma urea level is slightly reduced (Fig. 30 and 31). These findings 
present an interesting view on the role of EHD4 in the regulation of renal urea handling 
and urea gradient. EHD4-KO mice seem able to conserve the tissue urea gradient despite 
an apparent urea-wasting phenotype, at least when maintained on a normal protein diet. 
One possible explanation for this paradoxical finding between urea excretion and tissue 
urea gradient could be a reduced reabsorption of urea in the IMCD, where EHD4 is highly 
expressed, and an increased re-entry of urea from the vasculature into the interstitium.  
Principal cells of the IMCD express two urea transporters: UT-A1 in the apical 
membrane that transports urea from the luminal fluid into the principal cell, and UT-A3 in 
the basolateral membrane that transports urea from the inside of the principal cell to the 
renal interstitium (88). Absence of both UT-A1 and UT-A3 can result in a urine-
concentrating defect in mice (45), but only UT-A1, and not UT-A3, is required for basal 
urea permeability and a maximal urine-concentrating ability (92). Although some studies 
have highlighted the importance of endocytosis in the regulation of UT-A1 and -A3, there 
is no current report on the role of EHD proteins in the regulation of trafficking of these 
transporters. In the water restriction experiment, EHD4-KO mice was found to increase 
urine osmolality when water was restricted, but the urine osmolality remained lower than 
that in WT mice (Fig. 7B). This observation indicates that EHD4 is required for maximal 
urine-concentrating ability in mice. Moreover, an EHD-interacting protein, called Snapin 
(119), also interacts with UT-A1 (122). Combining these observations, it seems very likely 
that EHD4 may regulate the maximal urine-concentrating ability by regulating UT-A1 in 
the IMCD. Although the current results on the localization of UT-A1 in the principal cells 
needs further verification, it appears that EHD4 may regulate the accumulation of UT-A1 
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in the apical membrane of principal cells. In EHD4-KO mice, there seems to be a lack of 
UT-A1 in the apical membrane (Fig. 39) and this in turn might result in reduced urea 
reabsorption within the IMCD.  
It is also quite possible that the increased urea excretion in EHD4-KO mice may 
result due to the high urine flow in these mice. The high urine flow would allow less time 
for proper urea reabsorption in EHD4-KO mice, thereby increasing urea excretion. 
However, I would argue against this flow-induced increase in urea excretion in EHD4-KO 
mice. The data from the experiments involving modified protein diets showed that, at least 
in female mice, a high protein diet exacerbated the diuretic phenotype and further 
increased the urea excretion (Fig. 32), which was reversed by a low protein diet. These 
observations point more toward a defect in renal urea reabsorption in the absence of 
EHD4; however, it is also possible that EHD4 regulates the activity of UT-A2 in the thin 
descending limb. Data generated by Lee et. al. (104) from RNA sequencing of single 
tubules, shows that the expression of EHD4 mRNA is actually the highest in the thin limbs, 
which makes it possible for EHD4 to regulate UT-A2 as well. Therefore, a comprehensive 
profiling of the status of all arms of renal urea handling will be needed to confirm the exact 
role of EHD4 in this physiological process. 
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Conclusion and perspectives 
The functional data presented in this dissertation indicate an important regulatory 
role of EHD4 in the renal handling of both water and urea. The findings of these studies 
indicate that EHD4 does this, at least in part, through regulation of the subcellular 
localization of AQP2 and AQP4 in the collecting duct. Future studies are needed to fully 
elucidate the identity and cellular site of the urea transporter(s) regulated by EHD4, 
although UT-A1 appears to be a likely candidate. 
This study highlighted the potential impact on renal function of proteins involved in 
endocytic trafficking, which has received little attention so far. This study provides an 
insight into the cellular machineries that are involved in the regulation of water 
homeostasis. The exact roles of EHD proteins in humans and any pathophysiology 
associated with the lack of these proteins in humans has not been explored yet. This work 
has clinical relevance because an imbalance in body water can be fatal. In many clinical 
conditions, such as during nephrogenic diabetes insipidus, the water permeability is 
significantly reduced, resulting in a reduced reabsorption of water. EHD4-KO mice 
demonstrated a phenotype very similar to that seen during nephrogenic diabetes 
insipidus. One form of this disease occurs due a dysfunctional recycling of AQP2 in the 
principal cells. These findings shed an important light on the cellular processes involved 
in the trafficking of AQP2, as well as AQP4, that may be used in designing appropriate 
therapeutic agents. Targeted therapy is absolutely necessary for patients suffering from 
this disease because there are no treatment strategies available right now, and the only 
way to manage this condition is by monitoring fluid intake. Unresolved polyuria, such as 
during nephrogenic diabetes insipidus or acute renal failure, can raise the solute levels in 
the circulation and, thereby, can be fatal. In addition to polyuria, imbalance in body water 
can also occur during improper water retention, such as during congestive heart failure 
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(75). Increased expression and membrane accumulation of AQP2 has been shown to be 
one of the driving forces in the development of congestive heart failure (142). This work 
showed that EHD4 regulates AQP2 trafficking, thereby, providing a novel target for future 
work focusing on the designing of therapeutic agents to treat water imbalance and will 
likely prompt investigators in the future to explore whether reduced EHD4 expression or 
function might contribute to fluid imbalance in humans.  
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